Micro ds vuqlkj · Oracle cloud-based technologies into a single data management and warehousing...

8
Accenture Announces Collaboration With Bayer To Streamline Drug Development Processes Accenture has announced a collaboration with Bayer to implement the Accenture INTIENT Clinical platform to help simplify and speed its drug development processes. The platform, which went live at Bayer earlier this year, brings internal and external clinical data together with Oracle cloud-based technologies into a single data management and warehousing platform, creating actionable insights to accelerate drug development and improve patient outcomes. The Accenture INTIENT Clinical platform is part of Accenture INTIENT™ and builds upon Accenture’s market-proven platforms for research, clinical development, pharmacovigilance and patient services. It rapidly integrates new technology, advanced analytics and applied intelligence to support the delivery of patient treatments. Bayer has also joined the Life Sciences Cloud Coalition, which was developed to enable pre-competitive collaboration between pharmaceutical companies with the goal to more quickly and cost-effectively advance clinical development. The coalition brings together Oracle Health Sciences and R&D leaders from around the world to drive innovation and digitally enable the R&D function. Mike Stapleton, a managing director in Accenture’s Life Sciences practice, said: “We are excited to work with Bayer to provide new insights on their clinical trials, so they can bring the important treatments they develop to patients faster and with the highest quality. The future of R&D is bright when leading organiza- tions come together to solve for patients’ greatest needs.” The INTIENT Clinical platform was developed through an alliance between Accenture and Oracle. It combines Accenture’s proven implementation experience with solutions such as the Oracle Health Sciences Data Management Workbench and Oracle Life Sciences Data Hub. Together, these solutions generate high- quality, reliable data from clinical trials and reduce the time, effort and cost needed to take drugs from development to mar- ket. The Oracle solutions are powered by Oracle Cloud Infrastructure, sup- ported with Oracle Managed Cloud Services. “We welcome Bayer as a new member of the Life Sciences Cloud Coalition and to the Oracle Health Sciences Data Management Workbench family. Their perspective and experience will be invaluable in the advancement of clinical development for the entire industry,” said Steve Rosenberg, senior vice president and gener- al manager, Oracle Health Sciences. www.accenture.com. Siemens Healthineers Opens Future-Ready Medical Imaging Manufacturing Facility in India The next-gen facility collocated with the company’s R&D center at Bengaluru offers solutions from Diagnostic Imaging and Advanced Therapies l Strategically collocated with the company’s R&D center to deliver value to customers faster l The INR 200 million investment in the new manufacturing facility builds on the INR 25 billion invested in the R&D Center so far, exemplifies company’s enduring commitment to India l Production of mobile C-arm radiology system Cios Fit and computed tomography systems from the Somatom go. platform for the Indian and other emerging markets l Will start with around 70 employ- ees, workforce will be extended in three phases by fiscal year 2025 Technological advances are transforming the healthcare industry globally. As a part of its strategy for India, Siemens Healthineers will integrate manufacturing, technology and innovation functions at Bengaluru. Accordingly, the company has setup a new manufacturing facility that is collocated with its R&D center to better leverage syner- gies while developing offerings aligned to the future needs of its cus- tomers. Explaining the strategic significance of the manufacturing facility at the inauguration ceremony on September 19, 2019 in Bengaluru, André Hartung, Executive Vice President Computed Tomography and incoming President Diagnostic Imaging, Siemens Healthineers said, “Collocating a manufacturing facility with our R&D center in Bengaluru marks a significant step in strengthening our pres- ence in India, which is one of our important markets. It also reflects our enduring commitment to India, where we have been enabling bet- ter healthcare outcomes for over 90 years, manufacturing medical devices for 60 years, and advancing software excellence for over 25 years.” Gerd Hoefner, Managing Director and President, Siemens Healthcare Pvt. Ltd. added, “As Siemens Healthineers is leading the digitalization of healthcare, the collocation of the manufacturing with R&D center is especially important as it will enable us to deliver value to customers faster. Over the years, the R&D center at Bengaluru, has grown into a digital hub for the company accounting for over half of all the software engineering talent within Siemens Healthineers. It is also the largest such center within the company globally.” Talking about the products that will be made at the new facility, André Hartung said, “The facility will make computed tomography (CT) systems based on our trendsetting Somatom go. platform that we co-created with 500 customers in eleven countries. The new platform combines numerous software-led innovations with our novel detector technologies for rad- ically enhanced workflow efficiency, expanded clinical applicability, improved patient experience, and meeting the financial requirements of healthcare providers.” [email protected] Micro ds vuqlkj Micro Labs Ltd, Ph.- 080-22370451-57 ds vuqlkj dEiuh us ,d u;k Salt Mitroglycerin cktkj esa 2.5/6.5 mg dks ANGIPLAT czk.M uke ls ekdsZV esa mrkjk gS- dEiuh ds Teratory Manager Jh ekuosUnz dqekj xkSre Ph.-9759897116 us vius foftfVax dkMZ esa Angiplat esa Mitroglycerin dk mYys[k fd;k gS- nok O;olkf;;ksa dh tkudkjh ds vuqlkj ;g Nitroglycerin gS- Glenmark Pharmaceuticals receives ANDA approval for Clobetasol Propionate Foam, 0.05% (Emulsion Formulation) Mumbai:- Glenmark Pharmaceuticals Inc., USA (Glenmark) Mob:- 09999442531, 09319755551 has been granted final approval by the United States Food & Drug Administration (U.S. FDA) for Clobetasol Propionate Foam, 0.05% (Emulsion Formulation), a generic version of Olux®1 -E Foam, 0.05%, of Mylan Pharmaceuticals Inc. According to IQVIATM sales data for the 12 month period ending July 2019, the Olux®-E Foam, 0.05% market2 achieved annual sales of approximately $11.1 million*. Glenmark’s cur- rent portfolio consists of 161 products authorized for distribution in the U.S. marketplace and 54 ANDA’s pending approval with the U.S. FDA. In addition to these internal filings, Glenmark continues to identify and explore external development partnerships to supplement and acceler- ate the growth of its existing pipeline and portfolio. 1All brand names and trademarks are the property of their respective owners. 2Market includes brand and all available therapeutic equivalents *IQVIATM National Sales Perspectives: Retail & Non-Retail, July 2019.

Transcript of Micro ds vuqlkj · Oracle cloud-based technologies into a single data management and warehousing...

Page 1: Micro ds vuqlkj · Oracle cloud-based technologies into a single data management and warehousing platform, creating actionable insights to accelerate drug development and improve

Accenture Announces Collaboration With Bayer To Streamline Drug Development Processes

Accenture has announced a collaboration with Bayer to implement the Accenture INTIENT Clinical platform to help simplify and speed itsdrug development processes. The platform, which went live at Bayer earlier this year, brings internal and external clinical data together withOracle cloud-based technologies into a single data management and warehousing platform, creating actionable insights to accelerate drugdevelopment and improve patient outcomes. The Accenture INTIENT Clinical platform is part of Accenture INTIENT™ and builds uponAccenture’s market-proven platforms for research, clinical development, pharmacovigilance and patient services. It rapidly integrates newtechnology, advanced analytics and applied intelligence to support the delivery of patient treatments. Bayer has also joined the Life SciencesCloud Coalition, which was developed to enable pre-competitive collaboration between pharmaceutical companies with the goal to morequickly and cost-effectively advance clinical development. The coalition brings together Oracle Health Sciences and R&D leaders fromaround the world to drive innovation and digitally enable the R&D function. Mike Stapleton, a managing director in Accenture’s Life Sciencespractice, said: “We areexcited to work with Bayerto provide new insights ontheir clinical trials, so theycan bring the importanttreatments they developto patients faster and withthe highest quality. Thefuture of R&D is brightwhen leading organiza-tions come together tosolve for patients’ greatestneeds.” The INTIENTClinical platform wasdeveloped through analliance betweenAccenture and Oracle. Itcombines Accenture’sproven implementationexperience with solutionssuch as the Oracle HealthSciences DataManagement Workbenchand Oracle Life SciencesData Hub. Together, thesesolutions generate high-quality, reliable data fromclinical trials and reducethe time, effort and costneeded to take drugsfrom development to mar-ket. The Oracle solutionsare powered by OracleCloud Infrastructure, sup-ported with OracleManaged Cloud Services.“We welcome Bayer as anew member of the LifeSciences Cloud Coalitionand to the Oracle HealthSciences DataManagement Workbenchfamily. Their perspectiveand experience will beinvaluable in theadvancement of clinicaldevelopment for theentire industry,” saidSteve Rosenberg, seniorvice president and gener-al manager, OracleHealth Sciences.

www.accenture.com.

Siemens Healthineers Opens Future-ReadyMedical Imaging Manufacturing Facility in

IndiaThe next-gen facility collocated with the company’s R&D center atBengaluru offers solutions from Diagnostic Imaging and AdvancedTherapies l Strategically collocated with the company’s R&D center todeliver value to customers faster l The INR 200 million investment inthe new manufacturing facility builds on the INR 25 billion invested inthe R&D Center so far, exemplifies company’s enduring commitmentto India l Production of mobile C-arm radiology system Cios Fit andcomputed tomography systems from the Somatom go. platform for theIndian and other emerging markets l Will start with around 70 employ-ees, workforce will be extended in three phases by fiscal year 2025Technological advances are transforming the healthcare industryglobally. As a part of its strategy for India, Siemens Healthineers willintegrate manufacturing, technology and innovation functions atBengaluru. Accordingly, the company has setup a new manufacturingfacility that is collocated with its R&D center to better leverage syner-gies while developing offerings aligned to the future needs of its cus-tomers. Explaining the strategic significance of the manufacturingfacility at the inauguration ceremony on September 19, 2019 inBengaluru, André Hartung, Executive Vice President ComputedTomography and incoming President Diagnostic Imaging, SiemensHealthineers said, “Collocating a manufacturing facility with our R&Dcenter in Bengaluru marks a significant step in strengthening our pres-ence in India, which is one of our important markets. It also reflectsour enduring commitment to India, where we have been enabling bet-ter healthcare outcomes for over 90 years, manufacturing medicaldevices for 60 years, and advancing software excellence for over 25years.” Gerd Hoefner, Managing Director and President, SiemensHealthcare Pvt. Ltd. added, “As Siemens Healthineers is leading thedigitalization of healthcare, the collocation of the manufacturing withR&D center is especially important as it will enable us to deliver valueto customers faster. Over the years, the R&D center at Bengaluru, hasgrown into a digital hub for the company accounting for over half of allthe software engineering talent within Siemens Healthineers. It is alsothe largest such center within the company globally.” Talking about theproducts that will be made at the new facility, André Hartung said,“The facility will make computed tomography (CT) systems based onour trendsetting Somatom go. platform that we co-created with 500customers in eleven countries. The new platform combines numeroussoftware-led innovations with our novel detector technologies for rad-ically enhanced workflow efficiency, expanded clinical applicability,improved patient experience, and meeting the financial requirementsof healthcare providers.” [email protected]

Micro ds vuqlkjMicro Labs Ltd, Ph.- 080-22370451-57 dsvuqlkj dEiuh us ,d u;k Salt Mitroglycerincktkj esa 2.5/6.5 mg dks ANGIPLAT czk.M ukels ekdsZV esa mrkjk gS- dEiuh ds Teratory ManagerJh ekuosUnz dqekj xkSre Ph.-9759897116 us viusfoftfVax dkMZ esa Angiplat esa Mitroglycerin dkmYys[k fd;k gS- nok O;olkf;;ksa dh tkudkjh dsvuqlkj ;g Nitroglycerin gS-

Glenmark Pharmaceuticals receives ANDAapproval for Clobetasol Propionate Foam,

0.05% (Emulsion Formulation)Mumbai:- Glenmark Pharmaceuticals

Inc., USA (Glenmark) Mob:- 09999442531,

09319755551 has been granted final

approval by the United States Food & Drug

Administration (U.S. FDA) for Clobetasol

Propionate Foam, 0.05% (Emulsion

Formulation), a generic version of Olux®1 -E Foam, 0.05%, of Mylan

Pharmaceuticals Inc. According to IQVIATM sales data for the 12

month period ending July 2019, the Olux®-E Foam, 0.05% market2

achieved annual sales of approximately $11.1 million*. Glenmark’s cur-

rent portfolio consists of 161 products authorized for distribution in the

U.S. marketplace and 54 ANDA’s pending approval with the U.S. FDA.

In addition to these internal filings, Glenmark continues to identify and

explore external development partnerships to supplement and acceler-

ate the growth of its existing pipeline and portfolio. 1All brand names

and trademarks are the property of their respective owners. 2Market

includes brand and all available therapeutic equivalents *IQVIATM

National Sales Perspectives: Retail & Non-Retail, July 2019.

Page 2: Micro ds vuqlkj · Oracle cloud-based technologies into a single data management and warehousing platform, creating actionable insights to accelerate drug development and improve

ek¡ uonqxkZ dh 'kksHkk;k=kk 28 flrEcj dks

mn;iqj%& 'kwy/kfj.kh lsuk dh cSBd laHkkx dk;Zy; jsrhLVs.M fLFkr vkojhekrk eafnj ifjlj esa lEiUu gqbZ- cSBd esa ftyk ehfM;k izHkkjh lqfuy fuekor us tkudkjh nhfd gj o"kZ dh Hkkafr bl o"kZ Hkh uojkf=k dh ikouosyk ij laxBu }kjk ek¡ uo nqxkZ ,oa ek¡ vkojh ekrk dh HkO;fo'kky 'kksHkk;k=kk dk vk;kstu uojkf=k LFkkiuk ls ,d fnu iwoZ fnukd 28-9-2019 dks nksigj vkojhekrk eafnjizkax.k ls fudysxh- fuekor us crk;k fd iwjs jktLFkku esa ekrk ds ukS Lo:iksa dh 'kksHkk;k=kk ,oa LFkkiuk mn;iqjdh vuqBh igy lsuk }kjk dh tkrh gS- lkFk gh csVh cpkvksa csVh i<kvksa dk lans'k nsrs gq, tka,xs- cSBd esav'kksd tSu] jkds'k ekyh] iz'kkar rsyh] gknhZd rsyh] panu flag fllksfn;k] vfouk'k fllksfn;k vkfn ekStqn jgs-

& lqfuy fuekor] eksñ 09828046257-

Lupin Receives Health Canada Approval ForPropranolol Hydrochloride ER Capsules

Mumbai:- Pharma major Lupin Limited (Lupin) Mob:- 09922740085,

09812588360, 09212706200 announced that it has received approval forits Propranolol Hydrochloride Extended-Release (ER) Capsules, 60 mg,80 mg, 120 mg and 160 mg from Health Canada. Lupin is the first gener-ic company to receive an approval for generic Inderal®-LA Capsules forthe Canadian market and the product has been approved and will bemanufactured from Lupin’s Pithampur Unit-2 Facility. Lupin’s PropranololHydrochloride Extended-Release (ER) Capsules, 60 mg, 80 mg, 120 mgand 160 mg, are the generic version of Inderal®-LA Capsules, 60 mg, 80

mg, 120 mg and 160 mg of Pfizer Canada ULC, and are indicated in the treatment ofhypertension and for the prophylaxis of angina pectoris. Propranolol HydrochlorideExtended-Release (ER) Capsules (Canadian Reference Product: Inderal®-LA Capsules)had an annual sales of approximately CAD 8.6 million (MAT December 2018 IQVIA).

High Blood Pressure: 30-Minute Morning Workout Could Help To Control It

High blood pressure is a disease that afflicts people worldwide. Do you know that one in every three Indians is trou-bled by this situation? It may not be surprising that people are falling prey to this disease due to processed foodand busy/sedentary lifestyle. High blood pressurecan cause fatal diseases related to: l Heart lKidney l Eyes l Brain in people. Apart from med-icines, anybody can lower their BP naturally by mak-ing lifestyle changes. Some methods of dealingwith high blood pressure include: l Reducingsalt intake l High intake of potassium-rich foods lContinuing certain physical activities l Reducingalcohol intake l Quitting smoking 30 MinuteMorning Workout:- According to new research pub-lished in the American Heart Association Journal, a30-minute workout or physical activity in the morningcan help you reduce BP. It has positive effects onobese men and women. The study also showed thatwomen who take short and frequent breaks duringwork throughout the day may increase the benefitsof the workout. 55 to 80 years of age:- Men andwomen between the age of 55 to 80 years wereincluded in this study. Michael Wheeler, Ph.D.Candidate and lead author of the study, employed atthe Baker Heart and Diabetes Institute in Melbourne,Australia, and the lead author of the study, said,"Traditionally the health effects of workouts andsedentary lifestyle have been studied separately. Wedid this study because we wanted to know if there isa combination of these behaviors on blood pressurecan have a free effect". More attention to food andactivities:- The study included 67 participants andwas carried out on different scenarios. The identicalstudy was carried out in a controlled laboratory envi-ronment and participants were given standardizedfood. Their BP and adrenaline levels were repeated-ly tested. BP of people doing fewer workouts:-Researchers found that women and men who exer-cised in the morning had lower average blood pres-sure, especially systolic, than those who did not domorning workouts. At the same time, those womenwho exercised in the morning and took breaks atconstant intervals during work showed a significantreduction in mean systolic blood pressure. Womengot more benefits:- Wheeler stated, "A decrease inaverage systolic blood pressure for men and womenwho take breaks during work as well as performedworkouts can reduce the risk of death from heart dis-eases and stroke. However, this decrease is more inwomen". He also said that people who sit for longhours also benefited from taking breaks, especiallythose who had a higher risk of heart disease.Wheeler said, they want to focus on the aspect of: l Sitting people l Doing workouts with breaks The conclu-sion:- People should do at least 30 minutes of workouts along with a healthy diet to prevent hypertension.

3 o"kZ rd ?kj cSBs ;g lekpkj i=k i<+us ds fy;s gekjs iatkc uS'kuy cSad] cqyUn'kgj ds iQkekZ niZ.k [kkrk la[;k 1824002100118703] IFSC Code - PUNB0182400 Branch- Deputy Ganj esa gS] esa :ú 250@& tek dj viuk iwjk irk gekjs iQksu uaú& 09410434811 ij SMS dj nsaA

www.medicaldarpan.com

4th International Conference on Obstetrics andGynecology

Singapore:- It’s our pleasure to invite all the participants from all over the world to attendthe 3 rd International Conference on Obstetrics and Gynecology which is held duringNovember 14 – 15, 2019. The main theme of our conference is &quot; CurrentBreakthroughs and Innovative Approaches towards Improving Women&#39;sReproductive Health” which covers a wide range of critically important sessions.Gynecology 2019 is a unique forum that brings together worldwide renowned academi-cians from every field related to gynecology under a single roof. The meeting emphasizeson providing the ideal ambiance to broadcast and increase the current knowledge in thearena of Gynecology and Women Health. The two-day conference offers a plethora of mul-tifarious sessions like “Gynecologic Oncology, Midwifery, Abortion and Women Health,Clinical Sexology, Urogynecology, Maternal-Fetal Medicine, and Obstetrics, AestheticGynecology ”and much more. It hosts keynote forum, plenary lectures, poster sessions,exhibitions. Young Research Forum, B2B meetings, and workshops are the added high-lights of Gynecology 2019 conference. . It is our ideology to give a platform and exposureto our global attendees so that the event is a whisk that covers professionals such asResearchers, Gynecologists, Obstetricians, Veterans, Women’s Healthcare Professionalsfrom academia and different industries making the conference a perfect platform to shareand gain their knowledge. The Conference will likewise have a space for firms as well asfoundations to show their products, services, innovations and scientific results.

Conference Highlights:-

Gynecology and Obstetrics l BenignGynecologic Disease l GynecologicInfectious Diseases l GynecologicOncology and Screening l Breastcancer and Pregnancy/Lifestyle l

Reproductive Medicine and Fertility l

Reproductive Genetics l Maternal-FetalMedicine and Obstetrics l Trimester andNeonatology l Clinical Sexology and SexTherapy l Cosmetic and AestheticGynecology l Midwifery and GynecologyNurses l Medical Complications inPregnancy l Abortion and Women Health lMenstrual Cycle and Menopause l

Menstrual Disorders l Gynecological HealthDisorders l Polycystic ovarian syndrome andInfertility l Urology and UterineInfections/Diseases l Pediatric andAdolescent Gynecology l Palliative Care inObstetrics and Gynecology l GynecologyTest and Surgical Procedures l

Urogynecology and Reconstructive PelvicSurgery l Non-Hormonal Treatments inGynecology l IVF and AssistedReproductive Technology l Nutrition duringPregnancy and Drug Effects l PhysicalTherapy During Pregnancy l Contraceptionand Family Planning Let's meet in the City of Lion - Singapore.,

Contact Details:- Summer Watson, ProgramManager | Gynecology 2019Email:- gynecology@gynecologyconfer-

ences.com, Ph.:- +442037691755.

Page 3: Micro ds vuqlkj · Oracle cloud-based technologies into a single data management and warehousing platform, creating actionable insights to accelerate drug development and improve

vYtkbej ls cpko dh noktkudkjh feyh gS fd VsVªk FksjsI;wfVDl ds fodkl ds rgr chih,u14770 mu çfØ;kvksadks lfØ; djus esa enn dj ldrh gS tks raf=kdk ds LokLF; esa lg;ksx djrh gSa vkSjfMesaf'k;k dks jksdrh gS- 'kks/drkZvksa us nkok fd;k gS fd ;g nok ;knnk'r tkus] raf=kdk{kfr vkSj vYtkbej jksx ds vU; y{k.kksa ls cpk ldrh gS- çhfDyfudy 'kks/ dks tuZyvkWiQ iQkekZdksykWth ,aM ,DlisjhesaVy FksjsI;wfVDl esa çdkf'kr fd;k x;k gS- irk pyk gS fd nok&chih,u14770&veykWbM chVk ds çHkkoksadks jksdrh gS- veykWbM chVk] vYtkbej çksVhu dk gkWyekdZ gS] tks raf=kdk dksf'kdkvksa ds fy, fo"kkDr gksrk gS-

ww

w.m

ed

icald

arp

an

.co

m

dEifu;k¡ ftudh nok lcLVSaMMZ ik;h x;hM/s. Vivek Pharmachem (India) Ltd.Jaipur-303102 (Rajasthan). l M/s.Kwality Pharmaceuticals Ltd. Amritsar (Punjab) l M/s. Danish Health Care(P) Ujjain-456010 (M.P). l A. S. Lifesciences. 136, Ind.Estate Kutana-124001 (Haryana) India. l M/s. Nestor Pharmaceuticals Faridabad-121001(Haryana). l M/s. Sai Tech Pharmaceuticals Pvt. Ltd.,NaviMumbai-400705. l M/s. Jackson Laboratories Pvt. Ltd.,Amritsar-143001.Amritsar-143001. l M/s. Ciron Drugs & Pharmaceuticals Pvt Ltd., Palghar– 401506. M/S Jpee Drugs, Haridwar, (Uttarakhand). l M/s. ZimLaboratories Limited,Kalmeshwar-441 501, Dist. Nagpur, Maharashtra. lM/s. Karnataka Antibiotics & Pharmaceutical Limited,Bangalore-560058M/s. Oscar Remedies Pvt. Ltd. Nagar-135001(Haryana) l M/s. PansunPharmaceuticals Haridwar (Uttarakhand). l M/s.ANG Lifesciences IndiaLtd.M/s.ANG Lifesciences India Ltd.

Dr. Reddys Launches Generic Oral Anti Epileptic Drug In US

NEW DELHI:- Drug firm Dr. Reddy's Laboratories

Mob:- 09368696718, 09410210556, 09359503863,

09329621787, 09368010386 on Tuesday said it haslaunched generic anti-epileptic Vigabatrin powder

for oral solution in the US market. The product is a generic version ofLundbeck's Sabril powder for oral solution, Dr Reddy's said in a filing tothe BSE. The company has launched Vigabatrin powder for oral solu-tion, USP in 500 mg per packet after getting approval by the UnitedStates Food and Drug Administration (USFDA), it said. According toIMS Health data, Sabril brand and generic had US sales of around USD274 million (about Rs 1,900 crore) MAT for the most recent twelvemonths ending in June 2019, Dr Reddy's said. Sabril is indicated asadjunctive therapy for adults and pediatric patients of 10 years of ageand older with refractory complex partial seizures who have inade-quately responded to several alternative treatments and for whom thepotential benefits outweigh the risk of vision loss.

Cipla ClarificationRegarding

Partnership‘’ We have always stood for provisionof accessible and affordable health-care, improve ease of doing businessand formulate policies that aid thedomestic pharmaceutical industry. Inthis journey of ours, our channel part-ners have played a pivotal role in ourefforts to provide quality medicines tothe patients. We understand that thereare some unconfirmed media reportsin the market related to Cipla partner-ing with an e-pharmacy company. Wewish to emphasize that these mediareports are unsubstantiated and thereis no truth in the matter.’’ Hence as pertheir above clarification Cipla is notentering in any partnership with OnLine Pharmacies.

- Rajiv Singhal

Mob:- 09425056394.

fnyhi pkScs izQkWM gSnsgjknwu (U.K.) ds nok fuekZrk vHk; izrki flag] eksñ 07895988890 Mk;jsDVj NasaPharmaceuticals Pvt. Ltd. us Burdwan (W.B.) ds Valenta FormulationPvt. Ltd. ds Lokeh fnyhi pkScs eksñ 09831256980 dh f'kdk;r ehfM;k gkÅl ls dhgS vkSj crk;k gS fd bl izQkWM O;fDr us muls djhc 350]000 dk eky cuokdj iQthZpSd nsdj pSd ckmal djk fn;s gSSa vkSj vc ;g O;fDr iQksu ugha mBk jgk uk gh ekyokil dj jgk gS- vHk; izrki flag us ehfM;k gkÅl ds ekè;e ls lHkh nok fuekZrkvksadks lykg nh gS fd dksbZ Hkh dEiuh bl uñ 1 pksj dk eky uk cuk;sa-

MkWñ yksds'k xksYMu gsYFk ,aM,tqds'ku vokMZ ls lEekfur

nsgjknwu%& jklfcgkjh cksl lqHkkjrhfo'ofo|k; ds MkWñyksds'k R;kxh dks ubZfnYyh esa xksYMugsYFk ,aM ,tqds'kuvokMZ ls lEekfurfd;k x;k- csYyhek; ,oa lks'kyVkWDl dh vksj lsfnYyh esa vk;ksftr

vokMZ lekjksg dh vk;kstd lfpu xk¡/h uscrk;k fd ns'kHkj esa LokLF; vkSj f'k{kk esamRd`"V dk;Z djus okyksa dks lEekfur fd;kx;k- MkWñ yksds'k R;kxh dks lqHkkjrh fofo dsdqyifr MkWñ jke xqIrk] dqylfpr eukst flUgkvkSj iz'kklfud vf/dkjh johUnz izrki flag;kno us c/kbZ nh gS-

& yksds'k R;kxh] eksñ 09927094999-

Biocon Licenses Three Generic FormulationProducts to China Medical System Holdings

Agreement Extends Biocon’s Footprint to Greater China, the

World’s 2 nd Largest Pharma Market

Bengaluru, Karnataka:- Biocon Ltd.

Mob:- Asia’s premier biopharmaceuticalscompany, today announced that it hassigned a License and Supply Agreementwith a subsidiary of China Medical SystemHoldings Ltd. (CMS) for three Generic

Formulation products in Greater China. This development is in line withBiocon’s long term generic formulationsstrategy and expands our GenericFormulations business footprint to the Chinese pharmaceuticals market,which is the second largest pharmaceutical market in the world. Under theterms of the agreement, Biocon will be responsible for the development,manufacturing and supply of the products. CMS will be responsible for reg-istration and commercialization of the products in China. The totaladdressable market size for these three products in Mainland China isabout US$ 0.8 billion, as per recent IQVIA data. The initial term of theagreement shall be for 10 years from the date of commercialization,extendable by two years on a product basis by mutual consent. This col-laboration can be extended to a broader portfolio in future.

Page 4: Micro ds vuqlkj · Oracle cloud-based technologies into a single data management and warehousing platform, creating actionable insights to accelerate drug development and improve

E-derma Pharma India Pvt. Ltd. Antibiotics - AZICA Tablet : Azithromycin 250/500mg l AUG-FAST Tablet : (Amoxycillin Trih 500mg Potassium Clav. 125mg)l MINOPEARL Tablet : (Minocycline 50/100mg) l METATURNOintment : (Mupirocin 2%) l CEFITURN Tablet : (Cephalexin500 mg) l DALLOX Capsule : (Amoxycillin 250 mg &Dicloxacillin 250 mg) l DYNACLIN Tablet : (Clindamycin150/300 mg) l l DOXYAID-LB Capsule : (Doxycycline Hyclate100mg and 5 billion lactobacillus spores) l FUDICA Cream :(Fusidic acid 2%) l NADIREST Cream : (Nadifloxacin 1%)Antiallergic- E-BEST Tablet : Mizolastine 10 mg l

HYBEST-10/25 Tablet : (Hydroxyzine 10/25 mg) l

LORAID Tablet : (Loratadine 10 mg) l LEVOCA Tab/Syp: (Levocetirizine 5 mg) l LEVOCA-M Tablet :(Levocetirizine 5 mg & Montelukast 10mg) l POLBESTTablet : (Dexchlorpheniramine SR 2mg) l FEX-UP Tablet: (Fexofenadine 180 mg) l CALOMYNE Lotion :(Calamine 8%, Glycerin 5%, Aloevera 10% ,Liq. Paraffin ,Zinc Oxide 3%) Steroids - DYNACORT Tablet :(Deflazacort 6/12/30mg) l SAFECORT Cr/Lot. :(Mometasone Furoate 0.1%) l ECZIVATE 30 Cream :(Clobetasol Prop. 0.05%) l OFICA Cream : (Fluticasone0.05%) l HALOTURN Cream : (Halobetasol Prop. 0.05%)l FLUTURN-H Cream : (Fluocinolone Acetonide 0.1%) lNADIREST-M Cream : (Nadifloxacin 1% & Mometasone0.1%) l DESOCARE Lotion : (Micronised Desonide0.05%) l ECZIVATE-S Lotion : (Clobetasol 0.05% &Salicylic Acid 3/6%) l HALOTURN Lotion : (HalobetasolePropionate 0.05%) l ISORVATE-AL Gel : (Clobetasolprop. 0.05%, Ammonium Lactate 12%) l FUDICA-BCream : (Fusidic acid 2% & Mometasone Furoate 0.1%)Antifungal - ITRASTAT Capsule : (Itraconazole100/200mg) l TERBAZ Tablet : (Terbinafine 250 mg) lTERBAZ Cr/Dust. Powder : (Terbinafine 1%) l KTZTablet : (Ketoconazole 200 mg) l KTZ Cr/Dust. Powder :(Ketoconozole 2%) l KTZ Lotion : (Ketoconazole 2% Stay onLotion) l CANBEE Cream : (Clotrimazole 1% , CANBEE-BCream : Clotrimazole 1% & Beclomethasone 0.025%, SERTAFIXCream : (Sertaconazole 2.0% & Benzyl alcohol 1.0%) l K-WASHShampoo : (Ketoconazole 2%) l K-WASH PLUS Shampoo :(Ketoconazole 2% & ZPTO 1%) l FLUPACK Tablet :(Fluconazole 150 mg) l VORBERG Tablet : (Voriconazole 200mg) l LUNICOL Cream : (Luliconazole 1%) l AMLOTURNCream : (Amorolfine 0.025%) Immunosuppressants – AZONYTablet : (Azathioprine 50 mg) l TACROGARD 0.1/0.03Ointment : (Tacrolimus 0.1/0.03%) l SORAPRIN SoftgelCapsule : (Cyclosporine 100mg) l NEOTURN 2.5/5/7.5 Tablet :(Methotrexate 2.5/5/7.5 mg) Acne Care - ISOPEARL-M20Softgel Cap : (Micronised Isotretinoin 20mg) l ISOPEARL-10/20Softgel Cap : (Isotretinoin 10/20mg) l ISOPEARL-30 SoftgelCap : (Isotretinoin 30mg) l ISOTY Softgel Cap. : (Isotretinoin 20mg) l DYNACLIN-N Gel : (Clindamycin 1% & Nicotinamide 4%)l DYNACLIN Gel : (Clindamycin 1%) l O-GYL Gel :(Ornidazole 10 mg) l ADAQUEEN Gel : (Adapalene 0.01%) lADAQUEEN-C Gel : (Adapalene 0.01% & Clindamycin 1%) lTRET-A Cream : (Tretinoin 0.025%) l AZICA Gel :(Azithromycine 2%) l BENZITURN-AD Gel : (Adapalene 0.1% %benzoyl peroxide 2.5%) l Benziturn -2.5/5/10 Gel : (Benzoylperoxide 2.5/5/10%) Hyperpigmenting Agents - AZESPOTCream : Azelaic acid 15 % l FACELITE Gel : (Kojic Acid 2%,Arbutin 1.5%, Octinoxate 7.5%, Mulberry Extract & Glycolic Acid)l M-LITE PLUS Cream : (Hydroquinone 2%, Tretinoin 0.025%)l M-LITE FORTE Cream : (Hydroquinone 2%, Tretinoin 0.025%& Mometasone 0.1%) l M-LITE GLOW Cream : (Hydroquinone2%, Tretinoin0.025% & Fluocinolone Acetonide 0.01%) l M-LITEAT Cream : (Hydroquinone 2%, Tretinoin and Allantoin) l M-LITECream : (Hydroquinone 2%) l MELOSPOT Cream :(Hydroquinone 4%) l LITEFACE Cream : (Depigmenting Cream)l GLOW DAY Cream : (Glycolic acid, Alpha Arbutin, Tocopherylacetate, Resorcinol, Titanium Dioxide) l GLOW NIGHT Cream :(Alpha Arbutin, Retinol, Liquorice, Vit. E, Glycerine, Squalene, D-alpha Tocopherol, Lenolin) l GLUTAGLOW Tablet : (Glutathione500mg and Lipoic acid 200mg) l GLUTAGLOW-C Tablet :(Glutathione 500mg & Vitamin-C 500mg) l GLUTAGLOW Peel: (Glutathione 1%, Glycolic acid 45%, Lactic Acid 10%, Salicylicacid 0.5%, Kojic Acid Dipalmitate 7%, Lemon Peel Ext. 2%,Butyospermum Parkii 5%) l GLUTAGLOW-C Serum : (EthylAscorbic Acid Stable Vit. C 20%, Glutathione 2%, Niacinamide2%, Beta-Arbutin 2%, Orange Peel Extract 2%, Lemon Peel Ext.2%, Dimethicone 2%, Chamomila Ext. 2%) Antioxidants/Vitamins - LYCOXID Tablet : (Betacarotene (10%) 30 mg,Lycopene (10%) 7500 mcg, Vit. C 150 mg., Vit. E 25 mg, Minerals& Zeaxanthine (10%) 25 mg) l PROCDINA Tablet :(Proanthocyanidin 75 mg) l PROCDINA-TX Tablet :

(Tranexamic acid 250 mg) l IRONI UP Capsule : (Carbonyl Iron100 mg, Vit. C 150 mg, Vit. B12 15 mcg., Folic Acid 5 mg, ZincSulphate 61.8 mg & Vit B6 3 mg) Hair Care - FINTURN Tablet: (Finasteride 1 mg) l BIOTURN FORTE Tablet : (Biotin 10 mg,Calcium Pantothenate 100 mg, N-Acetyl Cysteine 50 mg,Minerals) l MINTURN-XL Lot/Spray : (Minoxidil 5% & Aminexil1.5%) l MINTURN-2/5/10 Lot/Spray : (Minoxidil 2/5/10%) lHAIR LONG Oil : (Sun flower Oil, Olive Oil, Amla Ext., Castor Oil,& Grapeseed Oil) l HAIR LONG Tablet : (Beta – Sitosterol100mg, Manganese 2mg, Vit. E 5mg, Green tea 50mg, Ginkgo

biloba 10mg, Nettle leaf extract 50mg, Amino acid, Vitamin B63mg, Collagen peptide 50mg & minerals) l HAIR LONG Serum: (Procapil, Keravis, Hydroxyethylcellulose, Tributyl Citrate,Germall, Propylyene Glycol, Polyquaternium) l Hair Long B +Oil : (Biotin, saw palmetto, D -panthenol, Sugandha Kokila,Seasame oil, roots of karonday, olive oil) l SOFTUM Shampoo :(Shea Butter, Ceramides, Soya protein) Soap/ Facewash - E-BACTY Soap : (Vit. E, Allantoin & Alum) l ACNEDAY Soap :(Triclosan, Triclocarben, Glycerin, Vit. E, Aloe Vera & Tree TeaOil) l GLOWBELLA ALOE VERA Soap : (Aloevera, Vitamin-E,Acetate & Glycerin) l KTZ Soap : (Ketoconazole 1%, ZPTO0.5%) l SCABICA Soap : (Permethrin 1%) l BEAUTY Bar :

(Aloe vera, Milk protein, Shea butter, Cocoa butter, Titanium diox-ide, Almond oil, Tree Tea Oil, Vit. E) l GLOWBELLA SOAP SkinWhitening : (Kojic acid, Arbutin, VIT A,C,E & F, Liquorice,Bearberry and Mushroom Extracts.) l SOFTUMBABY/Moisturizer Bar pH 5.5 : (Vit E, Syndet Base, SheaButter, Aloe Butter, Aloe Vera) l VISIA Soap : (Aloe Vera, Vit. E& Moisturising) l VISIA Facewash : (Lemon, Honey, Menthol,Mulberry Extracts) l ACNEDAY Facewash : (D-panthenol,Salicylic, Allantion, Witch Hazel, Aloe vera, Vit E & Triclosan) lSOFTUM Cleansing Lot. : (Cetyl Alcohol 2.65% and stearyl alco-hol 0.265) l GLOWBELLA Skin Whitening Facewash :(Salicylic, Kojic, Lactic and and Glycollic acid) Emollients - VISIACr/Lot. : (Glycerine 6.0%, Tocopheryl Acetate 0.5%, LiquidParaffin 10.0%, Cetyl Alcohol 3.0%, Squalene & Aloe Vera) lVISIA Soft Cream : (Propylene Glycol, Emulsifying wax,Glycerin, Cyclomethicon, ZnO CREAM) l VISIA Lip Balm : (LipCare Lip Balm) l GLOW BELLA moisturizing LOT : (GlycerylMonostearate, Glycerol, Caprylic/Capric Triglyceride, Aloe,Barbadensis Leaf Juice, Stearic Acid, Cetaearyl Alcohol,Butyrospermum Parkii (Shea Butter), Cyclopentasiloxane,Ethylhexylglycerin, Sodium PCA, Tocophery Acetate, Disodium

EDTA, Disodium EDTA, Allantoin For sensitive skin)Sunscreen - O' BAY SPF 30 + Sunscreen :(Octylmethoxycinnamate 5.0%, Avobenzone2.0%, Methoxy Cinnamidopropyl HydroxySultaine 2.0%, Zinc Oxide 2.0%, Allantion0.2%, Vitamin E 0.1%, Aloe Vera Gel 0.2%,Titanium Dioxide 2%) l VISIA SPF 50 +Sunscreen : (Octinoxate 7.5% ,Avobenzone2%, Oxybenzone 3%,Octocrylene 3%, ZnO2%, Titanium dioxide 3%) Psoriasis Care –TARSOFT-CS Ointment : (Clobetasol 0.05%,Salicylic Acid 3% & Coal Tar 5%) l ECZIVATE-MF Ointment : (Clobetasol 0.05%, SalicylicAcid 3%, Urea 10% & Lactic Acid 3%) l TAR-SOFT Lotion : (Coal Tar 4.25% & Salicylic Acid2%) l TARSOFT Ointment : (Salicylic Acid 3% & Coal Tar 6%) l Callove Ointment :

(Calicipotriol 0.005%) Antiscabies - IVITURN

Tablet : (Ivermectin 6/12 mg) l PERISH

Cream/Lotion : (Permethrin 5%) Antiviral – F-

VEER Tablet : (Famciclovir 250mg) Misc - D2

PLUS Tablet : (Diclophenac 50mg,Paracetamol 325 mg & Serratiopeptidase15mg) l PAPSODOM Tablet : (Pantoprazole40 mg. & Domperidone 10 mg) l FOUR

STROKE Cream : (Ofloxacin 0.75%,Ornidazole 2%, Terbinafine 1% & ClobetasolProp. 0.05%) l NEW LAUNCH : (MELOSPOTCREAM : Hydroquinone 4%, Octinoxate,Oxybenzone & Titanium Dioxide)

Mob:- 09034435000 09034635000.

Al Asia PharmacureSyrup/Suspension:- Allmin Forte (Multivitamins &Multiminerals) l Alplex Forte (B-Comlex With Lysine) l AlplexPlus (Lycopene, Vitamins, Minerals & Antioxidant) l MuleenForte (Ginseng, Vitamins, Minerals & Antioxidant) l Alfer-Plus(Ferrous Ascorbate & Folic Acid) Ayurvedic Syrup/Capsules:-Alzyme Fort (Digestive Enzymes) l Alive Ds (Sugar Free)(Liver Disorders Double Strength) l Shyfertone (Uterine TonicWith Benefits Of Lron) l Zymliv Pluse Syurp(Live+Enzyme+Antacid) Zymliv Plus Capsule (Enzyme

Capsules) l Re-Ortho 60 (Joint Pains) (CissusQuadrangularis & Withania Somnifera) l Uri Vedic 60 (ToControl Uric Acid Level) Dry Syrup/Syrup & Suspension:-Alycof-LS (Levosalbutamol, Ambroxol, Gauiphenesin) l

Alycof (Dextromethorphan, Chlorpheniramine Maleate) l

Alycof-T (Terbtaline, Bromhexine, Guaiphenesin, Menthol) lAlydex (Sugar Free) (Dextromethorphan, Bromhexine HCL,Ammonium Chloride, Menthol) l Alycof-Am (Sugar Free)(Ambroxol, Terbutaline, Guaiphenesin) l Alycof-D (Diphen.,Amm. Chloride, Sodium Citrate, Menthol) l Alycold (MangoFlavour) (Paracetamol, Phenylephrine, Cetrizine) l

Alycold-DS (Paracetamol 250 mg., Phenylephrine,Cetirizine) l Alyde-Plus (Aceclofenac & Paracetamol) lAlycid Gel (Sugar Free) (Megaldrate & Simethicone Mango,Mint & Saunf) l Alfime-LB (With Water) (Cefixime WithLactobacillus) l Alfime-O (With Water) (Cefixime WithOfloxacin) l Alyclav (With Water) (Amoxycillin, CalvulanicAcid) l Alycin (Mango Flavour) (Ofloxacin) l Alycin-M(Mango Flavour) (Ofloxacin, Metronidazole) Capsules AluAlu:- Al-Cobal-Plus (Methylcobalamin, Alpha Lipoic Acid,Vitamin B1, B6, D3 Folic Acid) l Alyvit Plus (Lycopene,Vitamin, Minerals) l All-Fit-Plus (Ginesng, Lycopene,Multivitamin) l Allmin Forte (Multivitamin, Multiminerals) lAllmin Gold (Multivitamin, Multiminerals With Ginseng) l

Alrab DSR (Rabeprazole With Domperidone) l Allmin ForteSoft Gel (Multivitamin & Multiminerals Softgel) l Lyzel SoftGel(Lycopene With Multivitamins) Tablets Alu Alu:- Alpane-SP(Aceclofenc, Paracetamol, Serratiopeptidase 15mg) l Alpane-MR (Aceclofenac, Paracetmol, Chlorozoxazone) l Alfime-LB100 (Cefixime With Lactic Acid Bacillus) l Alfime-LB 200(Cefixime With Lactic Acid Bacillus) l Alfer-XT (FerrousAscorbate, Folic Acid) l Alycort 6 (Deflazacort) l Mono-LC(Montelukast, Levocetirizine) Mob. :- 09855113546.

BiozenPaxitor CR (Paroxetine 125/25/37.5mg Controlled ReleaseTablets) l Presave-NT Plus (Pregabalin 75mg. S.R. +Nortriptyline 10mg. + Methylcobalamin-1500mcg.) l Xepam Plus(Escitalopram 10mg + Clonazepam 0.5mg Tablet) l Presave-NT(Pregabalin 75mg. + Nortriptyline 10mg.) l Xetopam-Plus(Escitalopram 10mg + Etizolam 0.5mg) l Xycovit-P (Pregabalin75mg S.R. + Methylcobalamin 750mg) l Biovert-OD (Betahistine48mg. Sustained Release) l Xycovit-GB (Gabapentin 300mg. +Methylcobalamin 500mg) l Biovert (Betahistine 8/16/24mg.) lXycovit-Gold (Elcosapentaenoic Acid, Docosahexaenioc Acid,ALA, Vitamins, Zinc, Selenium & Chromium, Folic AcidBelacarotene) l Stuvert (Cinnarizine 20mg. + Domperidone15mg. Tablet) l Xycovit (Methycobalamin 1500 mcg. + Pridoxine3 mg. + Folic Acid 1.5mg. + ALA 100mg.) l Stuvert-C (Cinnarzine25mg/75mg) l Bzcal-K2 (Calcium Carbonate 1.25gm. From anorganic Source (Oystershel) Eq. to Elemental Calcium 500mg +Calcitrol 0.25mcg + Vit. K2-750mcg. Magnesium 50mg. + Zinc7.5mg. Tablets) l Xelium-PRO (Flunarizine 10mg + Propranolol40mg S.R.) l Bzcal-60K (Cholecalciferol 60,000 IU Tablets) lXelium-5/10 (Flunarizine 5/10mg.) l Bzcal (Calcium Carbonate1250mg. From an organic Source (Oystershel) Eq. to ElementalCalcium 500mg + Calcitriol 0.25mcg) l Olanxit-F (Olanzapine5mg. + Fluoxetine 20mg.) l Defozone (Deflazacort 6/30mg.Tablets) lXepam (Clonazepam-0.5mg Tablet) lAuxib (Etoricoxib90mg/120mg Tab.) l Xetopam-10/20 (Escitalopram 10mg/20mg)l Auxidol-P (Aceclofenac 100mg. + Paracetamol 375mg) l

Restizol-L (Rebeprazole 20mg (Enteric Coated) + Levosulpiride75 SR) l Restizol-DSR/20 (Rebeprazole + (Domperidone-30SR/20) Mob:- +91-9889560800.

Shamac HealthcareRosuPrime-Gold (Rosuvastatin 10 + Aspirin 75 mg + Clopidogrel75 mg) l RosuPrime 10/20 (Rosuvastatin 10/20 mg) l

RosuPrime-A (Rosuvastatin 10 + Aspirin 75 mg) l TelmiBet40/80 (Telmisartan 40/80mg) l TelmiBet-AM (Telmisartan 40 &Amoldipine 5mg) l TelmiBet H (Telmisartan 40 &Hydrochlorothiazide 12.5mg) l TelmiBet Trio (Telmisartan 40,Amlodipine 5mg & Hydrochlorothiazide 12.5mg) l NeuroStepOD (Methylcobalamin 1500mcg, ALA 100mg, Pyridoxine 3.0mg,Folic Acid 1.5mg, Vit. D3 1000IU) Mob:- +919993400888.

Product List

AUTHORIZED DISTRIBUTORS

OF ADR Book

Location Shop Name Contact No.

Agra Satish Book Enterprises 9997877123

Allahabad Friends Book Depot 9451743891

Amritsar Rajat Book corner 9417381838

Amritsar Sunder Book Depot 9814074241

Barnala Navchetan Book Shop 9779050692

Dhule Kushal Book shop 9423916592

Dimapur Modern Book Depot 9436006701

Gwalior Unique Book Depot 9826257932

Haldwani Pooram & Sons 9837092823

Jodhpur Book World 9829088088

Kolkata Medicare Book House 9830518610

Muzaffarnagar Royal Pustak Bhandar 9761313181

Nanded Debdhar Pustak Bhandar 9423615127

Nasik Rahul Book Center 0253-2599608

Patna Current Book Services 9431077745

Raipur Srishti Medical Book House 9300855027

Reewa Palak Medical Book 9893793577

Tinsukia Sharma Book Stall 9435036146

Vishakhapatnam Andhra Medical Book Centre 9985716032

For ADR Booking Poonam Singhal, Mob.- 09219444474,

Abhay Singhal, Mob:- 09319980483.

Page 5: Micro ds vuqlkj · Oracle cloud-based technologies into a single data management and warehousing platform, creating actionable insights to accelerate drug development and improve

Farma HubTablets:- Akon-Xt (Ferrous Ascorbate Eq. to Lron 100mg + Folic Acid 1.5mg) l Amress-Al(Amlodipine 5 gm + Atenolol 50 mg) l Anlin-400 (Theophyllin Prolonged Rekease Ip 400 mg) lAzixime (Azithromycin 250 mg + Cefixime 200 mg) l Azixime LB (Azithromycin 250 mg + Cefixime200 mg + Lactic Acid 60 Million Spores) l Azixime Plus (Azithromycin 500 mg + Cefixime 200 mg)l Candifine Tf (Ltraconzole 100 mg + Terbinafine 250 mg) l Cefafar 250 Cefuroxime Axetil 250mg)l Cefafar 500 Cefuroxime Axetil 500mg) l Cefafar Cv 250 (Cefuroxime Axctil 250mg + PotassiumClavulanic 125mg) l Cefafar Cv 500 (Cefuroxime Axetil 500mg + Potassium Clavulanic 125mg) lCefizan Plus (Cefixime 200mg + ofloxacin 200mg) l Cefizna S (Cefixime 200 mg + Sulbactam 150mg) l Cefiway 200 Bb (Cefixime 200 mg + Lactic Acid 60 Million Spoers) Cefiway Plus (Cefixime200mg + Ofloxacin 200mg + Lactic Acid Bacillus) l Cefiway Oz (Cefixime 200mg + Omidazole500mg) l Chestwin (Paracetamol 325mg + Cetirizine 5 mg + Phenylephrine10mg) l Clonazan-Et(Clonazepam 0.5mg + Escitalopram Oxalate 10mg) l Defahub 6 (Deflazacort 6mg) l Doxyfine(Doxylamine Succinate 10mg + Pyridoxine Hydrochloride 10 mg) l Drotyfar-M (Drotaverone Hcl80mg + Mefanamic Acid 250mg) l Etohub 0.5 (Etizolam 0.5 mg) l Etohub 0.25 (Etizolam 0.25 mg)l Ex-Cv 375 (Amoxycillin Trihydrate 250mg + Clavulanic Acid 125mg) l Ex-Cv 625 (AmoxycillinTrihydrate 500mg + Clavulanic Acid 125mg) l Ex-Cv 625 Lb (Amoxycillin Trihydrate 500mg +Clavulanic Acid Bacillus) l Farchav-375 (Amoxycillin Trihydrate 250mg + Clavulanic Acid 125mg) lFarchav-625 (Amoxycillin Trihydrate 500mg + Clavulanic Acid 125mg) l Farclav-Kid (AmoxycillinTrihydrate 200mg + Clavulanic Acid 28.5mg) l Farcof Cold (Paracetamol 325 mg + Guaiphenesin100 mg + Ambroxol 30mg + Phenylephrine 10 mg + Cpm 10 mg) l Farcort 4 (Methyleprednisolone4 mg) l Farcort 8 (Methyleprednisolone 8 mg) l Farcort 16 (Methyleprednisolone 16 mg) lFarcoxia (Etoricoxib 90 mg) l Farnac-forte (Trypsin 48mg + Bromelain 90mg + Rutoside 100mg +Diclofenac Potassiun 50mg l Farna-p Aceclofenac 100mg + Paracetamol 325mg) l Farnac-p (Alu-Alu) (Aceclofenac 100mg + Paracetamol 325mg) l Farnac-Mr (Aceclofenac 100mg + Paracetamol325mg + Chlorzoxazone 250mg) l Farnac-sp (Aceclofenac 100mg + Paracetamol 325mg +Serratiopeptidase 15mg) l Faranc-th4 (Aceclofenac 100mg + Paracetamol 325 mg +Thiocolchicoside 4mg) l Farpod-O (Cefpodoxime Proxetil 200mg + Ofloxacin 200 mg) l Farpod100 (Cefpodoxime Proxetil 100mg) l Farpod 200 (Cefpodoxime Proxetil 200mg) l Farpod CV(Cefpodoxime Proxetil 200 mg + Pot. Clavulanate 125mg) l Farzyme Pancreatin 170 mg +Activates Dimethicone 80 mg) l Febufar 40(Febuxostate 40 mg) l Fixim 100 Dt (CefiximeTrihydrate 100mg) l Fixim 200 Dt (CefiximeTrihydrate 200mg) l Fixim 400 (CefiximeTrihydrate 400mg) l Fixim-Lb 50 Dt (Cefixime WithLactic Bacillus 50mg) l Fixim Plus (CefiximeTrihydrate 200mg + Ofloxacin 200mg) l Fungifar250 (Terbinafine 250 mg) l Fungifar 500(Terbinafine 500 mg) l Glyzan M1 (Glimepride 1mg + Metformin Hydrochloride 500 mg) l GlyzanM2 (Glimepride 2 mg + Metformin Hydrochloride500mg) l Glyzan Mv1 (Voglibose 0.1mg +Glimepride 2.0mg + Metformin Hydrochloride500mg) l Glyzan Mv2 (Voglibose 0.2 mg +Glimepride 2.0 mg + Metformin Hydrochloride 500mg) l Ishufee (Flupentixol 0.5 mg + Melitracen 10mg) l Joycin-500 (Levofloxacin 500mg) l JoycinOz (Levofloxacin 250mg + Ornidazole 500 mg) lKalen (Calcium Citrate 100mg + Calcitrol 0.25mg) lKalen K2 + (Vitamin K27 45mcg + Calcium Citrate1000mg + L-Methylfolate 1mg + CissusQuadrangularis 500 mg + Vitamin D3 1000 Ui) l Le-Jig (Levocetrizine 5 mg) l Linifine (Linezolid 600mg) l Lumefar (Artemether 80mg + lumefantrine) lMetfar-500 (Metformin 500 mg) l Moxyzan 250 DT(Amoxycillin Dispersible Tablets 250 mg) l Necfine-p (Diclofenac Sodium 50 mg + Serratiopeptidase10mg + Paracetamol 325mg) l Nipafar (Nimesulide100mg + Paracetamol 325mg) l Ketofar(Ketoconazole 200 mg) l Panfar 40 (Pantoprazole40 mg) l Panfar D (Pantoprazole 40 mg +Demeperidone 10 mg) l Parahub 650(Paracetamol 650 mg) l Parahub D (Paracetamol325 mg + Demoperidone 10 mg) l Rabyfar 20(Rabeprazole 20 mg) l Tamsufar-D (Tamsulosin0.5 mg + Dustasteride 0.4 mg) l Tanmink 20(Telmisarten 20 mg) l Tanmink 40 (Telmisartan 40mg) l Tanmink 40 H (Telmisartan 40 mg +Hydrochlorothiazide 12.5 mg) l Texazan- MF( T r a n e x a m i c Acid 500 mg + Mefenamic Acid 250 mg) l Tenzan(Trifluoperazine HCL 1 mg + Chloradiazepoxide 10mg) l Tenifar-20 (Teneligliptin Hydrobromidehydrate 20 mg) l Tenifar-M (TeneligliptinHydrobromide hydrate 20 mg + Metformin 500mg) lUdifine 150 (Ursodeoxycholic Acid 150mg) l

Udifine 300 (Ursodeoxycholic Acid 150mg) l

Udifine 300 (Ursodeoxycholic Acid 300mg) l

Udifine SL (Ursodeoxycholic Acid 300mg +Silymarin 140 mg) l Vertizan 8/16 (Betahistine Hydrochloride Tablets IP 8 mg /16mg) l Veebaz 250(Azithromycin Dinhydrate 250mg) l Veebaz 500 (Azithromycin Dihydrate 500mg) l Veebaz 500 Lb(Azithromycin Dihydrate 500mg + Lactic Acid Bacillus) l Vomifine (Ondansetron 4 mg) l Windfar-Fx (Montelukast Sodium 10mg + Fexofenadin Hydrochloride IP120mg) l Windfar-L (LevocetrizineHCL 5mg + Montelukast Sodium 10 mg) l Wisoflox 200 (Ofloxacin 200mg) l Wisoflox-oz(Ofloxacin 200mg + Ornidazole 500mg) l Xcitement (Jar) Sildenafil Citrate 100 mg) l Xcitement(Strip) Sildenafil Citrate 100 mg) l Zanofiram (Disulfiram tablets IP) l Zan-M-Spas (MefenamicAcid 250 mg + Dicyclomine Hydrochloride 10 mg) l Zincofar (Vitamins + Minerals + Natural Extract+ Nutritional food Suppliments) Capsules:- Candifine (Itraconazole 100 mg) l Candifine-200(Itraconazole 200 mg) l Cindaplay-300 (Clindamycin 300 mg) l Dirham (Omeprazole 20mg) lDirham-D (Omeprazole 20mg + Domeperidone 10mg) l Esofar-Dsr (Esomeprazole 40mg +Domeperidone 30mg) l Farclox (Ampicillin 250mg + Dicloxacillin 250 mg) l Farnac Rz(Aceclofenac 200mg + Rabeprazole 20 mg) l Lycofar (Lycopene 10% 5000mcg + Beta Carotene(7.5% dispersion) 20mg + Mecobalamin 250mcg + Vitamin B6 3mg + Folic Acid 1.5mg + ChromiumPicolinate 75mcg + Green Tea Extract 50% 200mg + Sodium Selenite100mcg + Zinc SulphateMonohydrate 27.453mg) l (Mecozone-Pg (Mecobalamine 750mg + Pregabalin 75 mg) l Moxyzan250 (Amoxycillin 250 mg) l Moxyzan 500 (Amoxycillin 500 mg) l Necessity (Methylcobalamin1000mcg + Benfotiamine 100mg + Pyridoxine Hcl 1.5mg + Alpha Lipoic Acid 0.75mg) l Panfar Dsr(Pantoprazole Sodium 40mg + Domeperidone 30mg) l Panfar-L (Pantoprazole 40 mg +Levosulpiride 75 mg) l Platimmune (Carica Papaya Extract 200 mg + Tinospora Extract 150 mg +Goat Milk Powder 100 mg + Vitmin E 40 mg + Wheatgrass Extract 50 mg + Kiwi Extract 50 mg +Pomegranates 50 mg) l Rabyfar-DSR (Rabeprazole Sodium 20mg + Domepridone 30mg) lRabyfar IT (Rabeprazole Sodium 20mg + Itopride 30mg) l Rabyfar L (Rabeprazole 20 mg +Levosulpride 75 mg) l Silyzan (Silymarin, L-Omithine, L-Aspartate, Folic Acid, Nicotinamide,Calcium D-Pantothenate, Thiamine Mononitrate, Riboflavin & Pyridoxine Hydrochloride) l Zynagut(Prebiotic & Probiotic Cap) l Zactovit Liquid:- Akon Xt (Ferrous Ascorbate 220.5 mg + ElementalIron 30 mg + Folic Acid 550 mcg) l Akon Xt (Ferrous Ascorbate 220.5 mg + Elemental Iron 30 mg

+ Folic Acid 550 mcg) l Apyfar (Cyproheptadine Hcl Ip 2mg + Tricholine Citrate 275mg) lChestwin (Paracetamol 125 + Cetirizine 2 mg + Pheylephrine 5 mg) l Covent-LC (CodeinePhosphate 10mg + Triprolidine Hydrochloride 1.25mg) l Covent-LC (Codeine Phosphats 10mg +Chloropheniramine 4mg) l Coviplex (Lycopene 6% 2000 mcg + Niacinamide 25 mg + PyridoxineHydrochloride 1.5 mg + Cyanocobalamin 1 mcg + Sodium Selenate 10 mcg + Zine Gluconate 3 mg+ Potassium Lodine 100 mcg + Manganese Sulphate 2 mg + Copper Sulphate 500 mcg FlavourBase Syp.) l Defahub (Deflazacort Oral Suspension 6mg) l Farcof-AB (Ambroxol 15mg +Terbutaline Sulphate 1.5mg + Menthol 1mg) l Farcof-CD (Codeine Phosphate 10mg +Chloropheniramine 4mg) l Farcof-D (Chlorpheniramine Maleate 2 mg + Dextromethorphan HydroBromide 10mg + Phenylephrine Hydrochloride 5mg (With Carton) l Farcof- LS (LevosalbutamolHydrochloride 1 mg + Ambroxol Hydrochloride 30 mg + Guaiphenesin 50 mg) l Farcof- P(Paracetamol 125mg + Chloropheniramine Maleate 1mg + Dextromethorphan Hydrobromide 5mg)l Farcof-Sf (Chlorpheniramine Maleate 2 mg + Dextromethorphan Hydrobromide 10mg +Phenylephrine Hydrochioride 5mg (With Carton) (Sugar Free) l Farlax (Lactulose 10gm) l Farnac-P (Aceclofenac 50mg + Paracetamol 125mg (With Carton) l Farzyme (Fungal Diastase 50 mg +Pepsin 10 mg) l Farflux-O (Sucralfate 1 mg + Oxetacaine 20 mg) l Joycin OZ (Levofloxacin 125mg + Ornidazole 125 mg) l Kalen (Calcium Carbonate With Vitamin D3 Suspension) l Lycofar(Lycopene 6% Minerals With Antioxidant Syp) l Necessity (L-Lysine Hydrochloride 10.0mg +Lycopene 6% Omcg + Vitamin A 1250. Oip + Cholecalceferol 100.Oip + V Vitamin E S Oip (As D-LAlpha Tocopheryl Acetate) + Cyanocobalamin 0.5mcg + Sodium Selenate Eq. To Selenium 17.5mcg+ Vitamin C 25.Omcg + Thiamine Hydrocloride 1.0 mg + Riboflavin Sodium Phosphate 1.5mg +Pyridoxime Hydrochloride 0.75mg + Copper Sulphate 100.Omcg + Potassium Iodide 50.Omcg +Zinc Sulphate Eq. To Elemental Zinc 1.5mg In A Flavoured Syrupy Base) l Parahub Ds(Paracetamol 250mg) l Parahub MF (Mefenamic Acid 50mg + Paracetamol 125mg) l Pulmozan(Acebrophylline 50mg + Guaiphenesin 50mg + Terbutaline Sulphate 1.25mg) l Raceone(Raceadotril Ip 10 mg. Suspension) l Silyzan Syp (Silymarin With B-Complex Susp.) l Utility(Uterine Tonic) l Vanbion-L (Thiamine Hydrochloride 2mg + Riboflavine Sodium Phospate 2.5 mg+ Pyridoxine Hydrochloride 0.75 mg + Niacinamide 15 mg + D-Panthenol 3 mg + Cynocobalamin 1mcg + L-Lysine 375 mg) l Veebaz 200 (Azithromycin Dihydrate 200mg) l Ventmino LS Junior(Levosalbutamol Hydrochloride 1 mg + Ambroxol Hydrochloride 30 mg + Guaiphenesin 50 mg)Liquid:- Windfar L (Montelukast Sodium 4 mg + Levocetirizine Dihychloride 2.5 mg) l Wisoflox

(Ofloxacin 50mg/5ml) l Wisoflox-OZ (Ofloxacin50mg + Ornidazole 125mg) l Zanfast Magaldrate480 mg + Simethicone 20 mg + Domperidone 10mg) l Zanfast (Magaldrate 480 mg + Simethicone20 mg + Domperidone 10 mg) l Zanfast OXOxetacaine 10 mg + Aluminium Hydroxide 291 mg+ Magnesium 98 mg) l Zanliv (Strong Liver Tonic)Dry Syrup:- Farpod (Cefpodoxime Proxetil 50mg /5ml) l Farpad 100 (Cefpodoxime Proxetil 100mg) lFarpod Cv (Cefpodoxime Proxetil I.P 50 mg +Potassium Clavulanate Diluted 31.25 mg) l

Farclav (Amoxycillin 200mg + Clavulanic Acid28.5mg) l Farclav DS (Amoxycillin 400mg +Clavulanic Acid 57mg) l Fixim (Cefixime Trihydrate50mg / 5ml) l Zynagut (Prebiotic & ProbioticGranules For Oral Suspension) l Linifine(Linezolid Dry Syp) Drops:- Akon (Iron CholineCitrate 50 mg + Lysine Hydrochloride 50 mg +Vitamin B12 2mcg + Folic Acid 100 mcg +Niacinamide 5 mg + Copper Sulphate 10 mcg +Zinc Sulphate Monohydrate 1 mg) l Colizan(Simethicone 40mg + Dill Oil 0.005ml + Fennel Oil0.0007mg) l Farcof Cold (Paracetamol 125mg +Phenylepherine Hcl 5mg + ChlorpheniramineMaleate 2mg) l Farpod PD (Cefpodoxime Proxetil)l Farzyme (fungal Diastase (1.800) 20mg +Caraway Oil 400 mcg + Cinnamon Oil 200 mg +Caradamon Oil 400 mcg + Simethicone 40 mg +Petsin 10 mg) l Sai- Dom (DomperidonSuspension) l Vomifine (Ondansetron 2 mg) lZincofar (Multiviamin Drops) Ear Drops:- Earfine(Gentamycin Sulphate + BeclomethasoneDiprolonate + Clotrimazole + LignocaineHydrochloride) Injections:- Akon (Iron SurcroseInj) l Cefafar-1Gm (Ceftria Xone 1gm) l Cefafar250 (Ceftria Xone 250mg) l Cefafar-500 (Ceftria500 mg) l Cefafar- S 375 (Ceftriaxone 250mg +Sulbactum 125mg) l Cefafar- S (Cefriaxone 1mg +Sulbactum 500mg) l Farcit Inj (Citicolin sidium Inj250 mg) l Farclav Inj 1.2Gm (AmoxycillinTrihydrate 1000mg + Clavulanic Acid 200mg(WithWFI) l Farmazone- SB (CefoperazoneSodium 500mg + Sulbactam Sodium 500mg) l

Farnac-AQ (Diclofenac 75 mg) l Lumefar (AlphaBeta Artemether) l Mecofine (Mecobalamin 1500mcg) l Mecofine (Dispo) (Mecobalamin 1500 mcg)l Mecofine Gold (Methylcobalamin 1500 mcg +Niacinamide 100 mg + D-Panthenol 50 mg +Vitamin B6 100 mg + Benzyle Alcohol 2 5% V/V) l

Mikazone-500 (Amikacin 500 mg) l Ndfine 50 (Nandrolone Decanoate 50 mg) l Panfar-IV(Pantoprazole Sodium 40mg) l Supataz 4.5 Gm (Piperacillin Sodium 4gm + Tazobactam Sodium500mg) l Serbact (Cefoperazone Sodium 1gm + Sulbactam Sodium 500mg) l Tramfar (TramadolHydrochloride 50 mg) l Vomifine (Ondansetron 2 mg) Cream:- Clobyway (Clobetasole +Miconazole + Neonycin Cream) l Candifine TF (Itraconazle + Terbinafine Hcl) l Eberplay(Eberconazole 1 % W/W) l Farfin (Amorolfine 0.25% W/W) l Ketosteel-KT (Clobetasole +Neomycin + Itaconazole + Tolnaftate + Iodochlorohydroxyquinoline Cream) l Lulfar (Luliconazole1% W.W.) l New Shine (Hydroquinone Usp 2%W/W + Tretinoin Usp 0.025%W/W + MometasoneFuroate Ip 0.1%W/W Scheme (With Soap) l New Shine Herbal (Fairness Herbal Cream) l NewShine Acne Gel (Adapalene 0.1% + Clindamycin Phosphate Ip 1%) l Fungifar (Cloetasole,Miconazole & Neomycin Cream) l PHF (Monetasone Furoate - 0.1% + Fusidic Acid - 2%) OilOintment:- Farnac Oil (For Joints Pain & Osteoarthritis Linseed Oil 3.00%W/W +DiclofenacDiethylamine 1.16%W/W + Menthol 5.00W/W% +) l Farnac Gel (Methyl Salicylate 10.00W/W% +Benzyl Alcohol 1.00W/W) Dusting Powder:- Fungifar - TF (Terbinafine 2 % W/W) l Fungifar - CT(Clotrimazole 1 % W/W) Powder:- Progud- DHA(Protein Powder With Dha & Methylcobalamine(Chocolate Flavour) Tin Pack l Necessity Powder (Energy Powder ( Lemon And Orange Flavour)Soap/Shampoo:- New Shine Soap (Alovera 4 % W/W + Glycerine IP 1% W/W ,Vitamin E Ip 0.25% W/W , Safflower Oil 0.5% , & Skimmed Milk Powder 2% & Soap Noodles Q.S) l Newshine Acne(Acne Soap) l Ketofar Shampoo (Ketoconazole IP 2% W/W) l Ketofar Soap Keloconazole 2%W/W) Soft Gel:- Kalen (Calcitriol IP 0.25 mcg + Calcium Carbonate IP 500mg + Zinc 7.5 mg SoftGel Capsules Of Omega-3 Fatty Acids + geen Tea Extract + Ginkgo Biloba +) l Turbo Gold (GrapeSeed Extract + Antioxidants+ Vitamins + Minerats + Trace Elements (With Carton) Paste:- AquaSense (Potassium Nitrate 5% W/W) Mouth Wash:- Aqua Sense (Chlorhexidine Mouthwash I.P. 0.2W/W) Face Wash:- Newshine Herbal (Neem + Alovera + Tulsi Facewash (Mono Carton) Sachets:-Kalen Sachet (Cholecalciferol Sachet) l L-AP Granules (L-Arginine & Proanthocyanidin Sachet) lHepa Powder (Amino Acid Granules) Mob:- 08171011413, 09837187230.

3 o"kZ rd ?kj cSBs ;g lekpkj i=k i<+us ds fy;s gekjs iatkc uS'kuy cSad] cqyUn'kgj ds tks fd iQkekZ niZ.k [kkrk la[;k 1824002100118703] IFSC Code - PUNB0182400 Branch- Deputy Ganj ds uke ls gS] esa :ú 250@& tek dj viuk iwjk irk gekjs iQksu uaú& 09410434811 ij SMS dj nsa-

Product List

Page 6: Micro ds vuqlkj · Oracle cloud-based technologies into a single data management and warehousing platform, creating actionable insights to accelerate drug development and improve

Greenleaf FormulationTablets:- CHOLEAF-60K (HOLECALCIFEROL-60000 I.U CHEWABLE TABLETIN ORANGE FLAVOUR) l LEAFCID JUNIOR 15 (LENSOPRAZOLE 15MGDISPERSIBLE TABLETS IN ORANGE FLAVOUR) l LEAF-CID JUNIOR 30(LENSOPRAZOLE 30MG DISPERSIBLE TABLETS IN ORANGE FLAVOUR) lLEAFCIN-200 (OFLOXACIN 200MG) l LEAFCIN-OZ (OFLOXACIN 200MG,ORNIDAZOLE 500MG) l GRECEFF-100 (CEFIXIME 100MG DISPERSIBLETABLETS) l GRECEFF-200 (CEFIXIME 200 MG DT,LACTOBACILLUS 250MILLION SPORES DISPERSIBLE TABLETS) l GRECEFF-OF (CEFIXIME200MG,OFLOXACIN 200MG) l GRECEFF-AZ 250 (CEFIXIME200MG,AZITHROMYCIN 250MG) l GRECEFF-OZ (CEFIXIME200MG,ORNIDAZOLE 500MG) l GRECEFF-CV (CEFIXIME 200MG, CLAVU-LANIC ACID 125MG) l CEFPOLEAF-100 (CEFPODOXIME PROXETIL 100MGDISPERSIBLE TABLETS) l CEFPOLEAF-200 (CEFPODOXIME PROXETIL200MG DISPERSIBLE TABLETS) l CEFPOLEAF-CV (CEFPODOXIME PROX-ETIL 200MG, CLAVULANIC ACID 125MG) l CEFPOLEAF-OF (CEFPODOXIMEPROXETIL 200MG, OFLOXACIN 200MG) l CEFPOLEAF-AZ (CEFPODOXIMEPROXETIL 200MG, AZITHROMYCIN 250MG) l LEAFCLAV-625 (AMOXY-CILLIN 500MG,CLAVULANIC ACID 125MG) l LEAFCLAV-375 (AMOXYCILLIN250MG, CLAVULANIC ACID 125MG) l LEAFZOLID-600 (LINEZOLID 600MG)l FAROLEAF (FAROPENAM SODIUM EXTENDED RELEASE 200MG) l SLT-375 (SULTAMICILLIN 375MG) l AZROLEAF-250 (AZITHROMYCIN 250MG) lAZROLEAF-500 (AZITHROMYCIN 500MG) l LEVOFLAZ-500 (LEV-OFLOXACIN 500MG) l GREXIME-250 (CEFUROXIME AXETIL 250MG) lGREXIME-500 (CEFUROXIME AXETIL 500MG) l LEAFNIM-MD (NIMESULIDE100MG MOUTH DISSOLVING TABLET IN ORANGE FLAVOUR) l LEAFNIM-SPAS (NIMESULIDE 100MG, DICYCLOMINE HCL 10MG) l LEAFNIM-P(NIMESULIDE 100 MG, PARACETAMOL 325 MG) l PAINLEAF-SPAS (DICY-CLOMINE HCL 20MG, PARACETAMOL 325MG) l PAINLEAF-650 (PARACETA-MOL 650MG DISPERSIBLE TABLETS) l PAINLEAF-1000SR (PARACETA-

MOL 1000MG SUSTAINED RELEASE) l LEAFCAM-20 (PIROXICAM 20MG DISPERSIBLE TABLETS) l LEAFLAM-PLUS (ACECLOFENAC 100MG, THIOCOLCHICOSIDE 4MG) l LEAFLAM-TH(ACECLOFENAC 100MG, PARACETAMOL 325MG, THIOCOLCHICOSIDE 4MG) l LEAFLAM-P (ACECLOFENAC 100MG, PARACETAMOL 325MG DISPERSIBLE TABLETS) l LEAFLAM-SP (ACE-CLOFENAC 100MG, PARACETAMOL 325MG, SERRATIOPEPTIDASE 15MG) l LEAFLAM-MR (ACECLOFENAC 100MG, PARACETAMOL 325MG, CHLORZOXAZONE 250MG) l FINELEAF-P(DICLOFENAC POTASSIUM 50MG, PARACETAMOL 325MG) l FINELEAF-SP (DICLOFENAC POTASSIUM 50MG, PARACETAMOL 325MG, SERRATIOPEPTIDASE 10MG) l FINELEAF-MR(DICLOFENAC POTASSIUM 50MG, PARACETAMOL 325MG, CHLORZOX-AZONE 250MG) l LEAFDOL-P (TRA- MADOL 37.5MG, PARACETAMOL325MG) l FINELEAF-SPAS (ACE- CLOFENAC 100MG, DROTAVERINE80MG) l XIBOTOR-90 (ETORICOXIB 90MG TABLET COLOUR ORANGE) lXIBOTOR-120 (ETORICOXIB 120MG TABLET COLOUR MAGENTA) l

XIBOTOR-PLUS (ETORICOXIB 60MG, PARACETAMOL 325MG) l XIBOTOR-TH (ETORICOXIB 60MG, THIO- COLCHICOSIDE 4MG) l GROW-SHINE (GROW-AMINO ACID, BIOTIN, CALCIUM PANTOTHENATE, MULTIVI-TAMINS, MULTIMINERALS) l GREA- CORT-6 (DEFLAZACORT 6MG) lISOLEAF-40 (SR) (ISOXSUPRINE 40MG SUSTAINED RELEASE) l

TRYMILIN-PLUS (TRYPSIN 48MG, BROMELAIN 90MG, RUTOSIDE TRI-HYDRATE 100MG, DICLOFENAC 50MG) l LEAFJOINT (DIACERIN50MG, MSM 250, GLUCOSAMINE 750MG) l GRESPAS-MF (DRO-TAVERINE 80MG, MEFENAMIC ACID 250MG) l VOMNICE-MD 4(ONDANSETRON HCL 4MG MOUTH DISSOLVING TABLET IN ORANGEFLAVOUR) l FULANGIL-150 (FLU- CONAZOLE 150MG) l FABITAST-40(FEBUXOSTAT 40MG) l THY- ROLEAF-25 (THYROXINE SODIUM25MCG) l THYROLEAF-50 (THY- ROXINE SODIUM 50MCG) l THY-ROLEAF-100 (THYROXINE SODIUM 100MCG) l ZINTOLEAF-COLD(PARACETAMOL 325MG, LEVOCETI- RIZINE 2.5MG, PHENYLEPHRINE10MG, CAFFEINE 30MG) l LEAFNIM- CC (NIMESULIDE 100MG, PARAC-ETAMOL 325MG, PHENYLEPHRINE HCL 10MG, CETIRIZINE HCL 5MG,CAFFEINE 25MG) l ZINTOLEAF (LEVOCETIRIZINE 5MG) l ZIN-TOLEAF-M KID (LEVOCETIRIZINE 2.5MG, MONTELUKAST 4MG) l ZIN-TOLEAF-M (LEVOCETIRIZINE 5MG, MONTELUKAST 10MG BILAYEREDTABLET) l ZINTOLEAF-AM (LEVO- CETIRIZINE 5MG, AMBROXOL 60MG)l ZINTOLEAF-PLUS (LEVOCETI- RIZINE 5MG, MONTELUKAST 10MG,ACEBROPHYLLINE 200MG (SR) l ZINTOLEAF-FORTE (LEVOCETI-RIZINE 5MG, MONTELUKAST 10MG, AMBROXOL 75MG) l FEXOGREN-M( F E X O FA N A D I N E 1 2 0 M G, M O N - TELUKAST 10MG BILAYEREDTABLET) l LINHISTIN-16 (BETAHIS- TINE 16MG) l PREGALEAF-SR(PREGABALIN 75MG SUSTAINED RELEASE), METHYLCOBALAMIN1500MCG) l LEAFCOB-NT (PREGA- BALIN 75MG, NORTRIPTYLINE10MG)l LEAFCOB-ALA (MECOBALAMIN 1500MCG, ALPHA LOPIC ACID 100MG, FOLIC ACID 1.5MG, PYRIDOXINE 3MG, THIAMINE 10MG) l LEAFCOB-MNT (PREGABALIN 75MG, METHYLCOBAL-AMIN 1500MCG, NORTRIPTYLINE10MG) l LEAFPRIN-40SR (ISOXSUPRINE 40MG(SR) l PLEAF-40 (PANTOPRAZOLE 40MG) l PLEAF-D (PANTOPRAZOLE 40MG, DOMPERIDONE 10MG)RABLEAF-20 (RABEPAZOLE 20MG) l RABLEAF-D (RABEPAZOLE 20MG, DOMPERIDONE 10MG) Mob.:- +91 9317777888.

Spl Healthcare India Pvt. Ltd.SOAP:- ACNE CARE SOAP (TEA TREE OIL,JOJOBA OIL WALNUT LEAF EXTRACT,VITAMIN E & ALLANTOIN SOAP) l CLINTOP SOAP (KOIJ ACID,WAL-NUT LEAF EXT,KUIKUI NUT OIL,JOJOBA OIL,TEA TREE OIL, & ALLANTOIN SOAP) l KESAR BABY SOAP (KESAR,VITAMIN E,ALOE VERA,ALMOND OIL& OLIVE OIL SOAP) l SCABINA GT SOAP (GAMMA BENZENE & CETRIMIDE SOAP) l SCABINA PLUS SOAP (KETOCONAZOLE,CETRIMIDE & MENTHOLSOAP) l SCABINA SOAP (PERMETHRIN SOAP) l SEASONS SOAP (VITAMIN E,ALOEVERA,HONEY & GLYCERINE SOAP) l SPL NEEM SOAP

(NEEM,TULSI,ALOE VERA & LEMON SOAP) l SULF SOAP (PRECIPITATED SULPHUR & SALICYLIC ACID SOAP) LIQUID ORAL (ALLOPATHIC):-

AMBROZET LS SYRUP (AMBOXOL. GUIAPHENESIN & LEVOSALBUTAMOL SYRUP (30/50/1) l ANACID MPS SUSPENSION (ALUMINIUMHYDROXIDE,MAGNESIUM HYDROXIDE & SIMETHICONE SUSPENSION (250,200,50) l AZIMET-100 SUSPENSION (AZITHROMYCIN 100MG SUSPEN-SION) l AZIMET-200 SUSPENSION (AZITHROMYCIN 200MG SUSPENSION) l CETRAPHEN DS SUSPENSION (PARACETAMOL, CETIRIZINE & PHENYLE-PHERINE SUSPENSION (250/2.5/5) l CLIMEX PLUS COUGH SYRUP (DEXTROMETHORPHAN,PHENYLEPHERINE & CHLORPHENIRAMINE MALEATESYRUP (10,5,2) l COLDAMIN DROPS (PARACETAMOL,PHENYLEPHERINE & CPM DROPS) l CYCLOMET PLUS SUSPENSION (DICYCLOMINE HCL. &PARACETAMOL SUSPENSION (5/125) l CYPROMA PLUS SYRUP (CYPROHEPTADINE WITH TRICHOLINE CITRATE SYRUP) l CYPROMA PLUS SYRUP

(WITH DROPPER) (CYPROHEPTADINE WITH TRICHOLINE CITRATE DROPS) l CYPROSIL SYRUP (CYPROHEPTADINE 2MG.SYRUP) l DEXEPHEN PLUS

SUSPENSION (PARACETAMOL, PHENYLEPHERINE & CHLORPHENIRAMINE MALEATE SYRUP (250,5,2) l MEFMET DS SUSPENSION (MEFENAMIC ACID& PARACETAMOL (100/250) l SPASFRESH AD DROPS (DICYCLOMINE HCL.& SIMETHICONE DROPS) l SPASMIN AD DROPS (DICYCLOMINE HCL.&SIMETHICONE DROPS) l SPDEX-15 COUGH SYRUP (DEXTROMETHORPHAN,PHENYLEPHERINE & CHLORPHENIRAMINE MALEATE SYRUP(15,5,2) lTIMS DMR COUGH SYRUP(BOX) (AMBROXOL,DEXTROMETHORPHAN, CETIRIZINE & MENTHOL SYRUP(15,10,5,0.5) l TIMS DMR COUGH

SYRUP(NAKED) (AMBROXOL,DEXTROMETHORPHAN, CETIRIZINE & MENTHOL SYRUP(15,10,5,0.5) l ULTRACOLD DROPS (PARACETAMOL,PHENYLE-PHERINE & CHLORPHENIRAMINE MALEATE SUSPENSION (125,5,2) l ULTRACOLD DS SUSPENSION (PARACETAMOL,PHENYLEPHERINE & CHLOR-PHENIRAMINE MALEATE SUSPENSION (125,5,2) l ULTRACOLD SUSPENSION (PARACETAMOL,PHENYLEPHERINE & CHLORPHENIRAMINE MALEATESUSPENSION (125,5,2) LIQUID ORAL (NUTRACEUTICAL):- ALLVIT DROPS (MULTIVITAMIN & MULTIMINERAL DROPS) l CALWELL-D3 DROPS (CHOL-CALCIFEROL 400 IU DROPS(VITAMIN D3) l CINAFOL KIDS DROPS (FOLIC ACID,NIACINAMIDE & VITAMIN B12 DROPS) l FEFORANGE SYRUP (FERRICAMMONIUM CITRATE,FOLIC ACID &VIT B12 SYRUP) l FERIWELL SYRUP (FERROUS ASCORBATE,FOLIC ACID & VITAMINS SYRUP) l HAEMO PLUS

SYRUP (FERRIC AMMONIUM CITRATE,FOLIC ACID &VIT B12 SYRUP) Mob.:- +91 9979791155 MAIL : [email protected].

Product List

D.O.B. NAME FIRM MOB. CITY STATE

20.09.81 SHRI ATUL JUGSL KISHORE JI PAWAN AGENCICS 9421052400 GUNA MADHYA PRADESH

25.09.80 SHRI AJAY JAIN JI ROYAL CHEMIST 9828141317 UDAIPUR RAJASTHAN

30.09.79 SHRI AMIT JAISWAL JI PHARMA BIOTEEN 9898065950 AHMEDABAD GUJRAT

03.10.55 SHRI A.A. THOMAS JI TABOR MEDICAL 9594016464 THANE MAHARASHTRA

13.10.77 SHRI ABHISHEK VORA JI NEW HINDUSTAN AGENCIES 9420684002 WARDHA MAHARASHTRA

15.10.78 SHRI ANURAG CHATURVEDI JI NEW SUSHIL MEDICAL STORE 9412184370 AURAYA UTTAR PRADESH

17.10.75 SHRI AMIT GARG JI SHOL HELTH CARE INDIA (P)LTD 9219504233 UDHAM SINGH NAGAR UTTRAKHAND

17.10.82 SHRI ABHAY JAIN JI SHASHVAT TRADERS 9837183479 ROORKEE UTTRAKHAND

18.10.60 SHRI ANAND K.R. AGARWAL JI KUNJ BIHRI ENTERPRISES 9334377572 SAMASTIPUR BIHAR

19.10.47 SHRI ASHOK LUTHRA JI HARYANA MEDICAL STORE 9818637124 FARIDABAD HARYANA

flrEcj o vDVwcj ekg dsR;kSgkj

20-09-2019 "k"Bh Jk¼21-09-2019 lIreh Jk¼] dkyk"Veh]

egky{eh ozr iw.kZ] jksfg.kh ozr22-09-2019 v"Veh Jk¼] thforiqf=kdk ozr23-09-2019 uoeh Jk¼] 'kjn~dkyhu lEikr24-09-2019 n'keh Jk¼25-09-2019 bfUnjk ,dkn'kh] ,dkn'kh

Jk¼] n~okn'kh Jk¼26-09-2019 e?kk Jk¼] =k;ksn'kh Jk¼]

iznks"k ozr27-09-2019 prqnZ'kh Jk¼] ekfld f'kojkf=k28-09-2019 vf'ou vekoL;k] loZfi=kh

n'kZ vekoL;k] loZfi=kw vekoL;k29-09-2019 pUnz n'kZu] uojkf=k izkjEHk]

?kVLFkkiuk] egkjktk vxzlsu t;Urh02-10-2019 fouk;d prqFkhZ] yfyrk iapeh]

xk¡/h t;Urh03-10-2019 fcYo fueU=k.k] LdUn "k"Bh04-10-2019 ljLorh vkokgu] dYikjEHk]

vdky cks/u05-10-2019 ljLorh iwtk] uoif=kdk iwtk]

uoin vksyh izkjEHk06-10-2019 ljLorh cfynku] nqxkZ v"Veh]

lfU/ iwtk] egk uoeh07-10-2019 nqxkZ cfynku] ljLorh foltZu]

vk;q/ iwtk] nf{k.k ljLorh iwtk] caxkyegk uoeh] cq¼ t;Urh

08-10-2019 nqxkZ foltZu] n'kgjk]fot;n'keh] caxky fot;n'keh] eSlwj nljk]

fon~;kvkjEHke~ dk fnu] eèokpk;Z t;Urhs09-10-2019 ikikadq'kk ,dkn'kh10-10-2019 iÁukHk n~okn'kh11-10-2019 iznks"k ozr13-10-2019 vf'ou iwf.kZek] dkstkxj iwtk]

'kjn iwf.kZek] iwf.kZek miokl] okYehfdt;Urh] ehjkckbZ t;Urh] uoin vksyh iw.kZ

14-10-2019 dkfrZd izkjEHk16-10-2019 ekfld dkfrZxkbZ17-10-2019 vV~y rnh] djok pkSFk]

lad"Vh prqFkhZ18-10-2019 rqyk laØkfUr] jksfg.kh ozr

Happy Birthday

eSMhdy niZ.k ehfM;k gkÅl dh rjiQ ls vki lHkh dks tUe fnu dh gkfnZd 'kqHkdkeuk;sa

Page 7: Micro ds vuqlkj · Oracle cloud-based technologies into a single data management and warehousing platform, creating actionable insights to accelerate drug development and improve

(AIOCD) In Its Recent Meet Held On August 27 With MinisterAll India Organization of Chemists and Druggists (AIOCD) in its recent meet held on August 27 with Minister ofState for Chemicals and Fertilizers Mansukhlal Mandaviya urged deletion of online prescription and to address theissue of data confidentiality on e-pharmacy. All the concerns of AIOCD were deliberated and noted by the Minister.The minister was in agreement to the issues raised and directed department heads to find out time bound solu-tions regarding thesame. AIOCD also

urged the gov-ernment to con-sider issueswhich weretaken up in thedraft onlinepharmacy notifi-cation and alsoaddress drugaddiction issuesdue to indis-criminate onlinesales anda n t i m i c r o b i a lr e s i s t a n c e(AMR). Whilethe Minister dur-ing the meetstressed that

confidentiality ofpatient data is avery sensitive issueand asked officialswhether this provi-sion has beenincluded in the draftnotification, AIOCDGeneral SecretaryRajiv Singhal point-ed out how can thesecurity of data beassured online.AIOCD President JS Shinde exudedoptimism on itsmeet with theMinister on onlinepharmacy issues. Adelegation led by JS Shinde had metthe Minister.

Ministry Has Directed States To CreateIntelligence Cells

With an aim to check illegal practices of manufacturing spuriousdrugs, the Health Ministry has directed states to create intelli-gence cells to expose and bust such rackets. These intelligencecells will work in coordination with the officers of state drugdepartments and the Central Drug Control StandardOrganisation (CDCSO) to unearth the illegal activities of spuri-ous drugs and their manufacturing units. The intelligence cellswill also look for any contravention of the Drug and Cosmetic Act.The health ministry has sought all state drug controllers to strict-ly monitor the implementation of the intelligence cells under theAct. These directions were given at the third Annual RegulatorsConclave for Central and State Regulatory Authorities recentlyheld in Goa. "Already some states like Maharashtra, AndhraPradesh, Goa and Delhi have their respective intelligence cellsand they are doing good. The intelligence cells will create moresurveillance. This will also help in sampling to ensure qualityissues of drugs and pharmaceuticals. Also, it will help the depart-ment by infrastructure and manpower," a senior drug controllertold ANI on condition of anonymity. "The intelligence cells willconduct surprise raids and inspections. They will keep a strictvigil on habitual offenders. They will also make out a plannedstrategy with focused modus operandi. The intelligence cells willgenerate a database to capture historical background and inci-dences," the official said. Informing about one such racket ofspurious drugs which was unearthed by the Delhi Drugs ControlDepartment, the official said, "In Delhi, huge stocks of ointmentsof leading brands namely Betnovate-C, Betnovate-N andPanderm ++ were recently recovered from Bawana area. Theestimated cost ofrecovered goodsis stated to beapproximately Rs1.4 crore." Whencontacted, AtulNasa, who isHead ofOffice/Controllingand LicensingAuthority in Delhisaid, "It was achallenging tasktaken by the offi-cers of drug con-trol department byexposing theracket of manu-facturing of spurious and counterfeit medicines of multinationalbrands." "Our drug inspectors had also collected the samples ofall three drugs from the spot for analysis to ascertain the qualityof drugs and to verify their genuineness. GSK company has nowverified that it is a spurious sample and not manufactured by theparent company," Nasa added.

3 o"kZ rd ?kj cSBs ;g lekpkj i=k i<+us ds fy;s gekjs iatkc uS'kuy cSad] cqyUn'kgj ds tks fd iQkekZ niZ.k [kkrk la[;k 1824002100118703] IFSC Code - PUNB0182400 Branch- Deputy Ganj ds uke ls gS] esa :ú 250@& tek dj viuk iwjk irk gekjs iQksu uaú& 09410434811 ij SMS dj nsa-

Zydus Cadila Receives Nod From DrugController General Of India

New Delhi:- Zydus Cadila Mob:-

09368696718, 09410210556,

09359503863, 09329621787,

09368010386 on Tuesday said it has

received marketing authorisation for

Twinrab, used for treating rabies, from

the Drug Controller General of India (DCGI). “The novel bio-

logic which will be marketed under the brand name, Twinrab,

is indicated in combination with rabies vaccine for rabies

post-exposure prophylaxis,” Zydus Cadila said in a state-

ment. Rabies, a viral disease which gets transmitted through

the bite of a rabid animal, affects the central nervous system.

Page 8: Micro ds vuqlkj · Oracle cloud-based technologies into a single data management and warehousing platform, creating actionable insights to accelerate drug development and improve

fudq¡t Lokeh dh vksj ls czts'k dqekj xxZ }kjk izdkf'kr] czts'k dqekj xxZ }kjk eqfær rFkk bEizzs'kal fizafVax ,.M iSfdax fyfefVM uks,Mk] xkSre cq¼ uxj esa eqfær ,oa ch0,u0 eSMhdy dkWEIySDl] cqyUn'kgj ls izdkf'kr lEiknd& czts'k dqekj xxZ

ww

w.m

ed

icald

arp

an

.co

m

prqo"khZ; pquko lEiUu (ikyh jktLFkku)

vè;{k% Jh jktsUnz esgrk eksñ 09414120754 lfpo% euh"k tSu eksñ 09214421940 dks"kkè;{k% /uat; pkS/jh eksñ 09460730330 mikè;{k%fouksn flag eksñ 09413605317 lglfpo% egsUnz vxzoky eksñ 09414526252

& ftrsUnz xgyksr eksñ 09828473588] Vardhman Medical & General Store, yfyr 'kekZ eksñ 08218202588 us tkudkjh nh gS-

egsUnz vxzokyfouksn flag/uat; pkS/jheuh"k tSujktsUnz esgrk

Cipla Has Clarified That It Has “No Plans” To Venture Into E-pharmacy

New Delhi:- Mumbai-based drug maker Cipla Mob:- 09335391184, 09760122456,

09759395698 has clarified that it has “no plans” to venture into e-pharmacy, looking to paci-fy a powerful lobby of over 8.5 lakh chemist outlets that threatened to boycott the compa-ny’s products. “We understand that there are some unconfirmed media reports in the mar-ket related to Cipla partnering with an e-pharmacy company. We wish to emphasise thatthese media reports are unsubstantiated and there is no truth in the matter,” Cipla told theAll India Organisation of Chemists and Druggists (AIOCD) in an emailed statement Friday.Earlier this week, the AIOCD said it was planning to sideline and stop promoting products

manufactured by India’s third largest pharmaceuticals company after learning about its reported tie-up withonline pharmacy chain, Medlife. In its email, Cipla told AIOCD that it values the role of offline chemists. “We havealways stood for provision of accessible and affordable healthcare, improve ease of doing business and formu-late policies that aid the domestic pharmaceutical industry. In this journey of ours, our channel partners haveplayed a pivotal role in our efforts to provide quality medicines to the patients.” AIOCD general secretary RajivSinghal confirmed to ThePrint that the lobby has received the email. “As per the clarification sent by Cipla in themail to us, the company is not entering in any partnership with online pharmacy,” he said. ThePrint reached Ciplafor comment on its email to the lobby but there was no response until the time of publishing this report.

Nucala Is The First Biologic Approved In The US For Six To 11-year-Old Children With Severe Eosinophilic Asthma

GlaxoSmithKline:- announced that the US Food and Drug Administration (FDA)has approved Nucala (mepolizumab) for use in children as young as six years oldwho are living with severe eosinophilic asthma. Nucala is the only targeted bio-logic to be approved for the condition in the six to 11-year age group in the US.Dr Hal Barron, Chief Scientific Officer and President, R&D, GSK, Mob:-

09711110134, 09873604249 said: “Children with severe eosinophilic asthma currently have limited treatmentchoices available to them. We believe this important new indication for Nucala is a significant developmentfor these children and their families”. Tonya Winders, CEO and President, Allergy and Asthma Network, noted:“As a mother of children who suffer from asthma, I know first-hand the huge impact it has on a family, fromthe constant worry about your child being hospitalised, to practical issues like arranging time off work to carefor them. Having Nucala approved as the first biologic for treating severe eosinophilic asthma in this youngage group represents a significant step forward for the asthma community.” The FDA approval is supportedby an open-label study, conducted in children aged six to 11 years and suffering from severe eosinophilicasthma, that investigated Nucala’s pharmacokinetics, pharmacodynamics and long-term safety. Evidencefrom adequate and well-controlled trials in adults and adolescents also supported approval in this age group.The 52-week long-term phase of the study showed that the safety profile in paediatric patients aged six to 11years was similar to the known safety profile in patients aged 12 years and older. Dr Daniel Jackson, MD,Department of Pediatrics, University of Wisconsin, added: “Severe eosinophilic asthma in children is a com-plicated condition that can be extremely challenging to treat. Nucala has made a difference for many adultsand adolescents living with severe asthma. This approval is an important development, giving physicians likeme a much-needed option to consider for our paediatric patients”. Nucala (100mg dose subcutaneous injec-tion) was first approved in 2015 as an add-on maintenance treatment for patients with severe eosinophilicasthma aged 12 years and older. This approval (40mg dose subcutaneous injection) extends the current indi-cation in the US for Nucala to patients aged six to 11 years. Nucala has been approved for use as an add-ontreatment for severe eosinophilic asthma in patients aged six years and older in the EU since August 2018.

Dr. Reddy's Laboratories Announces TheLaunch Of Fosaprepitant For Injection In

The U.S. MarketHyderabad:- Dr. Reddy’s Laboratories Ltd.

Mob:- 09305730890,09058458612,

9368696718, 9305730890 along with its sub-sidiaries together referred to as “Dr. Reddy’s”)today announced the launch of Fosaprepitant for

Injection, the therapeutic generic equivalent of EMEND® (fosaprepi-tant) for injection, approved by the U.S. Food and Drug Administration(USFDA). “We are pleased to be among the first generics to launchthis product,” explains Marc Kikuchi, Chief Executive Officer, NorthAmerica Generics, Dr. Reddy’s Laboratories. “This is a great additionto our injectable portfolio in the U.S. market as we continue to aug-ment our product offering and drive growth for the hospital segment.”The EMEND® for Injection brand had an U.S. sales of approximately$279 million MAT for the most recent twelve months ending in July2019 according to IQVIA Health*. Dr. Reddy’s Fosaprepitant forInjection is available in 150 mg single-dose vial for reconstitution.EMEND® is a trademark of Merck Sharp & Dohme Corp.

uojk=kksa esa ek¡ ds ukS :iksa dh efgekek¡ 'kSyiq=kh

'kSy dk vFkZ gS f'k•j- nqxkZ dks 'kSy iq=kh Hkh dgk tkrk gS] ;g cgqrfnypLi ckr gS- tc ÅtkZ vius f'k•j ij gksrh gS] dsoy rHkh vki'kq¼ psruk ;k nsoh :i dks ns•] igpku vkSj le> ldrs gSa- mllsigys] vki ugha le> ldrs] D;ksafd bldh mÙifr f'k•j ls gh gksrhgS- fdlh Hkh vuqHko ds f'k•j ls ;fn vki 100» Øksf/r gSa] rksvki ns•sa fd fdl çdkj Øks/ vkids lkjs 'kjhj dks tyk nsrk gS-fdlh Hkh pht dk 100» vkids lEiw.kZ vfLrÙo dks ?ksj ysrk gS&rc gh okLro esa nqxkZ dh mRifÙk gksrh gS-

ek¡ dw"ek.Mk^dw* dk vFkZ gS NksVk] ^b'k* dk vFkZ gS ÅtkZ vkSj ^vaMk* dk vFkZ gSczãkaMh; xksyk& l`f"V ;k ÅtkZ dk NksVs ls o`gn czãkaMh; xksyk- ;g cM+sls NksVk gksrk gS vkSj NksVs ls cM+k_ ;g cht ls c<+ dj iQy curk gSvkSj fiQj iQy ls nksckjk cht gks tkrk gS- blh çdkj] ÅtkZ ;k psruk esalw{e ls lw{ere gksus dh vkSj fo'kky ls fo'kkyre gksus dk fo'ks"k xq.kgS_ ftldh O;k[;k dw"ekaMk djrh gSa-

ek¡ LdanekrkLdUnekrk oks nSoh; 'kfÙkQ gS tks O;ogkfjd Kku dks lkeus ykrh gS& oks tksKku dks deZ esa cnyrh gSa-

dkR;k;uhdkR;k;uh vKkr dh oks 'kfÙkQ gS] tksfd vPNkbZ ds Øks/ ls mRiUu gksrhgS- Øks/ vPNk Hkh gksrk gS vkSj cqjk Hkh- vPNk Øks/ Kku ds lkFk fd;ktkrk gS vkSj cqjk Øks/ Hkkoukvksa vkSj LokFkZ ds lkFk fd;k tkrk gS- Kkuhdk Øks/ Hkh fgrdj vkSj mi;ksxh gksrk gS_ tcfd vKkuh dk çse Hkh gkfuçngks ldrk gS- bl çdkj] dkR;k;uh Øks/ dk oks :i gS tks lc çdkj dhudjkRedrk dks lekIr dj ldrk gS-

dkyjkf=kdkyjkf=k nsoh ek¡ ds lcls Øwj] lcls Hk;adj :i dk uke gS- nqxkZ dk;g :i gh çÑfr ds çdksi dk dkj.k gS- çÑfr ds çdksi ls dgha Hkwdai]dgha ck<+ vkSj dgha lqukeh vkrh gS_ ;s lc ek¡ dkyjkf=k dh 'kfÙkQ lsgksrk gS- blfy;s] tc Hkh yksx ,sls çdksi dks ns•rs gSa] rks oks nsoh dslHkh ukS :iksa ls çkFkZuk djrs gSa-

egkxkSjhegkxkSjh] ek¡ dk vkBok¡ :i] vfr lqanj gS] lcls lqanj! lcls vf/ddksey] iw.kZr% d#.kke;h] lcdks vk'khokZn nsrh gqbZa- ;g oks :i gS] tkslc euksdkeukvksa dks iwjk djrk gS-

flf¼nk=khuoka :i] flf¼nk=kh] flf¼;k¡ ;k thou esa lEiw.kZrk çnku djus okyk gS-lEiw.kZrk dk vFkZ gS& fopkj vkus ls iwoZ gh dke dk gks tkuk] ;gh lEiw.kZrkgS- vki dqN pkgks vkSj oks igys ls gh ogk¡ vk tk;s- vkidh dkeuk mBs]blls igys gh lcdqN vk tk;s& ;gh flf¼nk=kh gS-

ek¡ czãpkfj.khczãpkfj.kh dk vFkZ gS vuar esa O;kIr] vuar esa xfreku & vlheczãk vlhe gS ftlesa lcdqN lekfgr gS- vki ;g ugha dg ldrsfd] ^eSa bls tkurk gw¡*] D;ksafd ;g vlhe gS_ ftl {k.k ^vki tkutkrs gSa*] ;g lhfer cu tkrk gS vkSj vc vki ;g ugha dg ldrsfd] ¶eSa bls ugha tkurk¸] D;ksafd ;g ogk¡ gS & rks vki dSls ughatkurs\ D;k vki dg ldrs gSa fd] ¸eSa vius gkFk dks ugha tkurk-vkidk gkFk rks ogk¡ gS u- blfy;s] vki bls tkurs gSa- czã vlhegS] blfy;s vki bls ugha tkurs& vki bls tkurs gSa vkSj fiQj Hkh vkibls ugha tkurs- nksuksa ! blhfy;s] ;fn dksbZ vkils iwNrk gS rks vkidks pqi jguk iM+rkgS- tks yksx bls tkurs gSa os cl pqi jgrs gSa D;ksafd ;fn eSa dgrk gw¡ fd] ¶eSa ughatkurk¸] eSa iw.kZr% xyr gw¡ vkSj ;fn eSa dgrk gw¡ fd] ¶eSa tkurk gw¡¸] rks eSa ml tkuusdks 'kCnksa }kjk] cqf¼ }kjk lhfer dj jgk gw¡- bl çdkj] czãpkfj.kh oks gS] tksfd vlheesa fo|eku gS] vlhe esa xfreku gS- xfrghu ugha] cfYd vuar esa xfreku- ;s cgqr ghjkspd gS& ,d xfreku gksuk] nwljk fo|eku gksuk- czãp;Z dk vFkZ gS rqPNrk esa u jguk]vkaf'kdrk ls ugha iw.kZrk ls jguk- bl çdkj] czãpkfj.kh psruk gS] tksfd loZ&O;kid gS-

ek¡ pUæ?kaVkçk;%] ge vius eu ls gh my>rs jgrs gSa& lHkh udkjkRed fopkjgekjs eu esa vkrs gSa] bZ";kZ vkrh gS] ?k`.kk vkrh gS vkSj vki mulsNqVdkjk ikus ds fy;s vkSj vius eu dks lkiQ djus ds fy;s la?k"kZdjrs gSa- eSa dgrk gw¡ fd ,slk ugha gksus okyk- vki vius eu lsNqVdkjk ugha ik ldrs- vki dgha Hkh Hkkx tk;sa] pkgs fgeky; ijgh D;ksa u Hkkx tk;sa\ vkidk eu vkids lkFk gh Hkkxsxk- ;gvkidh Nk;k ds leku gS- gk¡] çk.kk;ke] lqn'kZu fØ;k cgqrlgk;d gks ldrs gSa_ ij fiQj Hkh eu lkeus vk gh tkrk gS- eudks ?kaVs dh èofu ds leku Lohdkj djsa& ?kaVs dh èofu ,d gksrh

gS] ;g dgha ugha gks ldrh] ;g dsoy ,d gh èofu mRiUu dj ldrk gS& lHkh Nk;kvksads chp eu esa ,d gh èofu ! lkjh vLrO;Lrrk nSoh; 'kfÙkQ dk mn~Hko djrh gS& oksgS pUæ?kaVk vFkkZr~ pUæ vkSj ?kaVk-